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Abstract 
 
 
The adequacy of anesthesia has been studied since the introduction of balanced general 
anesthesia. Commercial monitors based on electroencephalographic (EEG) signal 
analysis have been available for monitoring the hypnotic component of anesthesia from 
the beginning of the 1990s. Monitors measuring the depth of anesthesia assess the 
cortical function of the brain, and have gained acceptance during surgical anesthesia 
with most of the anesthetic agents used. However, due to frequent artifacts, they are 
considered unsuitable for monitoring consciousness in intensive care patients. The 
assessment of analgesia is one of the cornerstones of general anesthesia. Prolonged 
surgical stress may lead to increased morbidity and delayed postoperative recovery. 
However, no validated monitoring method is currently available for evaluating 
analgesia during general anesthesia. 
 
Awareness during anesthesia is caused by an inadequate level of hypnosis. This rare but 
severe complication of general anesthesia may lead to marked emotional stress and 
possibly posttraumatic stress disorder. In the present series of studies, the incidence of 
awareness and recall during outpatient anesthesia was evaluated and compared with that 
of in inpatient anesthesia. A total of 1500 outpatients and 2343 inpatients underwent a 
structured interview. Clear intraoperative recollections were rare the incidence being 
0.07% in outpatients and 0.13% in inpatients. No significant differences emerged 
between outpatients and inpatients. However, significantly smaller doses of sevoflurane 
were administered to outpatients with awareness than those without recollections (p< 
0.05). 
 
EEG artifacts in 16 brain-dead organ donors were evaluated during organ harvest 
surgery in a prospective, open, nonselective study. The source of the frontotemporal 
biosignals in brain-dead subjects was studied, and the resistance of bispectral index 
(BIS) and Entropy to the signal artifacts was compared. The hypothesis was that in 
brain-dead subjects, most of the biosignals recorded from the forehead would consist of 
artifacts. The original EEG was recorded and State Entropy (SE), Response Entropy 
(RE), and BIS were calculated and monitored during solid organ harvest. SE differed 
from zero (inactive EEG) in 28%, RE in 29%, and BIS in 68% of the total recording 
time (p<0.0001 for all). The median values during the operation were SE 0.0, RE 0.0, 
and BIS 3.0. In four of the 16 organ donors, EEG was not inactive, and 
unphysiologically distributed, nonreactive rhythmic theta activity was present in the 
original EEG signal. After the results from subjects with persistent residual EEG 
activity were excluded, SE, RE, and BIS differed from zero in 17%, 18%, and 62% of 
the recorded time, respectively (p<0.0001 for all). Due to various artifacts, the highest 
readings in all indices were recorded without neuromuscular blockade. The main 
sources of artifacts were electrocauterization, electromyography (EMG), 50-Hz artifact, 
handling of the donor, ballistocardiography, and electrocardiography.  
  
In a prospective, randomized study of 26 patients, the ability of Surgical Stress Index 
(SSI) to differentiate patients with two clinically different analgesic levels during 
shoulder surgery was evaluated. SSI values were lower in patients with an interscalene 
brachial plexus block than in patients without an additional plexus block. In all patients, 
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anesthesia was maintained with desflurane, the concentration of which was targeted to 
maintain SE at 50. Increased blood pressure or heart rate (HR), movement, and 
coughing were considered signs of intraoperative nociception and treated with 
alfentanil. Photoplethysmographic waveforms were collected from the contralateral arm 
to the operated side, and SSI was calculated offline. Two minutes after skin incision, 
SSI was not increased in the brachial plexus block group and was lower (38 ± 13) than 
in the control group (58 ± 13, p<0.005). Among the controls, one minute prior to 
alfentanil administration, SSI value was higher than during periods of adequate 
antinociception, 59 ± 11 vs. 39 ± 12 (p<0.01). The total cumulative need for alfentanil 
was higher in controls (2.7 ± 1.2 mg) than in the brachial plexus block group (1.6 ± 0.5 
mg, p=0.008). Tetanic stimulation to the ulnar region of the hand increased SSI 
significantly only among patients with a brachial plexus block not covering the site of 
stimulation.  
 
Prognostic value of EEG-derived indices was evaluated and compared with Transcranial 
Doppler Ultrasonography (TCD), serum neuron-specific enolase (NSE) and S-100B 
after cardiac arrest. Thirty patients resuscitated from out-of-hospital arrest and treated 
with induced mild hypothermia for 24 h were included. Original EEG signal was 
recorded, and burst suppression ratio (BSR), RE, SE, and wavelet subband entropy 
(WSE) were calculated. Neurological outcome during the six-month period after arrest 
was assessed with the Glasgow-Pittsburgh Cerebral Performance Categories (CPC). 
Twenty patients had a CPC of 1-2, one patient had a CPC of 3, and nine patients died 
(CPC 5). BSR, RE, and SE differed between good (CPC 1-2) and poor (CPC 3-5) 
outcome groups (p=0.011, p=0.011, p=0.008, respectively) during the first 24 h after 
arrest. WSE was borderline higher in the good outcome group between 24 and 48 h 
after arrest (p=0.050). All patients with status epilepticus died, and their WSE values 
were lower (p=0.022). S-100B was lower in the good outcome group upon arrival at the 
intensive care unit (p=0.010). After hypothermia treatment, NSE and S-100B values 
were lower (p=0.002 for both) in the good outcome group. The pulsatile index was also 
lower in the good outcome group (p=0.004).  
 
In conclusion, the incidence of awareness in outpatient anesthesia did not differ from 
that in inpatient anesthesia. Outpatients are not at increased risk for intraoperative 
awareness relative to inpatients undergoing general anesthesia. SE, RE, and BIS showed 
non-zero values that normally indicate cortical neuronal function, but were in these 
subjects mostly due to artifacts after clinical brain death diagnosis. Entropy was more 
resistant to artifacts than BIS.  During general anesthesia and surgery, SSI values were 
lower in patients with interscalene brachial plexus block covering the sites of 
nociceptive stimuli. In detecting nociceptive stimuli, SSI performed better than HR, 
blood pressure, or RE. BSR, RE, and SE differed between the good and poor 
neurological outcome groups during the first 24 h after cardiac arrest, and they may be 
an aid in differentiating patients with good neurological outcomes from those with poor 
outcomes after out-of-hospital cardiac arrest.  
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Abbreviations 
 
 
AEP auditory evoked potential 
ASA American Society of Anesthesiologists 
BIS Bispectral Index Scale 
BPsys systolic blood pressure  
BSR burst suppression ratio 
cEEG continuous electroencephalography 
CI confidence interval 
CPC Cerebral Performance Categories 
CPP cerebral perfusion pressure 
CT computed tomography 
ECG electrocardiography 
EEG electroencephalography 
EMG electromyography 
EP evoked potential 
ESR electroencephalogram silence ratio  
fEMG frontal electromyography 
FFT Fast Fourier Transformation  
FPR false-positive rate 
GABA A gamma-aminobutyric acid subtype A   
GCS Glasgow Coma Scale 
HACA  hypothermia after cardiac arrest  
HBI heart beat interval 
HBInorm normalized heart beat interval 
HR heart rate 
Hz hertz 
ICP intracranial pressure 
ICU intensive care unit 
kDa kilodalton 
kPa kilopascal 
μV microvolt 
mA milliampere 
MAC minimal alveolar concentration 
MCA middle cerebral artery  
MHz megahertz 
MLAEP middle latency auditory evoked potential 
N2O  nitrous oxide 
NIBP non-invasive blood pressure 
NICU neurological intensive care unit 
NIRS near-infrared spectroscopy  
NMBA  neuromuscular blocking agent 
NPV negative predictive value 
NSE neuron-specific enolase  
OAA/S  Observer’s Assessment of Alertness/Sedation scale  
Pk prediction probability 
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PPG pulse plethysmography 
PPGA  pulse photoplethysmographic amplitude 
PPV positive predictive value 
PRST pressure, rate, sweating, tears 
qEEG quantitative electroencephalography 
RASS Richmond Agitation-Sedation Scale 
RE Response Entropy 
ROSC return of spontaneous circulation  
SAS Sedation Agitation Scale 
SD standard deviation 
SE State Entropy 
SEP somatosensory-evoked potential 
SjVO2 jugular bulb venous oxygen saturation  
SPI Surgical Pleth Index 
SpO2 peripheral oxygen saturation  
SQI signal quality index  
SSI  Surgical Stress Index  
SVmR skin vasomotor reflex  
TCD  transcranial Doppler ultrasonography 
VF ventricular fibrillation  
WHO World Health Organization 
WSE wavelet subband entropy 
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1. Introduction 
 
 
Intraoperative awareness with recall is a rare but potentially serious complication of 
general anesthesia. Its incidence has declined during the last decades. Currently, 
outpatient-surgery comprises more than 50% of the total number of surgeries, and the 
proportion is rising. In outpatient surgery, one of the main goals is to conduct operative 
procedures cost-effectively. This puts pressure on reducing operating theater change-
over times and length of stay in the recovery room, thus necessitating the use of short-
acting anesthetics. This might increase the risk of awareness during outpatient 
anesthesia. 
 
Amnesia, analgesia, and immobility characterize modern balanced anesthesia. It has 
long been possible to measure the degree of muscle relaxation, and from the beginning 
of the 1990s, several EEG-based monitors have been used to evaluate the hypnotic 
component of anesthesia. The use of these depth-of-anesthesia monitors has been 
associated with a decreased incidence of awareness (Ekman et al. 2004, Myles et al. 
2004), reduced administration of hypnotic drugs (Gan et al. 1997, Vakkuri et al. 2005), 
faster recovery from anesthesia (Gan et al. 1997, Johansen and Sebel 2000, Vakkuri et 
al. 2005), and a lower incidence of postoperative vomiting (Nelskylä et al. 2001). The 
depth-of-anesthesia monitors can not predict patient’s movements or hemodynamic 
responses to surgical stimuli during general anesthesia (Johansen and Sebel 2000).  
 
Although analgesia is one of the main components of balanced general anesthesia, a 
commercially available monitor for assessment of analgesia does not currently exist. 
During surgery the stress response is an unconscious systemic reaction to tissue injury 
that reflects autonomic, hormonal, and metabolic changes (Desborough 2000). 
Prolonged surgical stress may cause biochemical body reactions, which may lead to 
increased morbidity and delayed postoperative recovery (Kehlet 1997). The Surgical 
Stress Index (SSI, later Surgical Pleth Index, SPI) was developed in an effort to obtain 
balance between nociception (caused by surgical stimulation) and antinociception 
(opioid analgesia or neural blockade). SSI is based on the interval between successive 
heartbeats (HBI) and the pulse photoplethysmographic amplitude (PPGA), which are 
obtained from the photoplethysmographic waveform of the peripheral oxygen saturation 
measurement. The measures are normalized and combined to produce a single SSI value 
(Huiku et al. 2007). SSI has been clinically validated (Ahonen et al. 2007, Huiku et al. 
2007, Struys et al. 2007), and will become commercially available in the near future. 
 
Evaluation of consciousness, level of sedation, and neurological status are daily 
problems in intensive care units (ICUs). Most critically ill patients suffer from diseases 
that may influence brain function. Even if neurological status remains normal during the 
ICU stay, patients are usually sedated to allow adequate treatment. Over-sedation is 
associated with an adverse outcome, and strategies designed to avoid this have been 
demonstrated to have a positive effect on outcome (Kress et al. 2000). Due to 
unconsciousness, evaluation of neurological status and prediction of outcome are 
difficult. Status epilepticus has been related to poor neurological outcome in critically ill 
patients (Young and Doig 2005, Rundgren et al. 2006). Nonconvulsive status 
epilepticus (NCSE, status epilepticus without visible seizure) has an incidence of 8% in 
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comatose ICU patients (Towne et al. 2000). Longer seizure duration and delay to 
diagnosis are associated with increased mortality (Young et al. 1996). NCSE is 
detectable only with EEG monitoring, which supports the inclusion of continuous EEG 
in routine evaluation of comatose patients even when clinical seizure activity is not 
apparent; in addition, muscle relaxants will mask the clinical signs. Neuromonitoring is 
needed also among stroke and neurosurgical patients, with the aim of detecting treatable 
conditions and reducing secondary brain damage following acute brain injury. A 
noninvasive neuromonitoring method is required. 
 
Automatic methods to measure the adequacy of the depth of anesthesia and analgesia in 
the operation theater and the level of consciousness in ICU, and possible artifacts 
related to these monitors were evaluated in this thesis. The incidence of awareness in 
outpatient anesthesia was also investigated. The monitors were evaluated in groups of 
patients for which they have not been previously tested or validated. Finally, the 
performance of the EEG-based indices was tested for the prediction of neurologic 
outcome in comatose ICU patients. 
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2. Review of the literature 
 
 
2.1. Mechanisms of general anesthesia  
 
 
According to current knowledge, most of the general anesthetics act via ligand-gated or 
voltage-gated channels on the main targets. Anesthetics interact with various molecular 
sites of neuronal action. They modulate the activity of ion channels and cause 
hyperpolarization of neurons in thalamocortical loops, thereby leading to disruption of 
effective connectivity in the cortex (Campagna et al. 2003, Århem et al. 2003). The 
effect of a certain drug depends on the connection and feedback in neural networks, and 
it may result in inhibition, excitation, or no effect on the central nervous system (Urban 
2002). Whether the anesthesia-induced unconsciousness is a direct effect of anesthetics 
on the cerebral cortex (Velly et al. 2007), a direct (Alkire and Miller 2005) or indirect 
effect (Alkire 1998) on the thalamus, or arises from thalamocortical interactions remains 
unclear (John and Prichep 2005). Anesthetics seem to cause unconsciousness by 
targeting posterior lateral corticothalamic complex around the inferior parietal lobe and 
the medial cortical core. Unconsciousness is caused by preventing interactions among 
specialized brain regions or by reducing the number of activity patterns available to 
cortical networks (Alkire et al. 2008). 
 
 
Most anesthetics act by either increasing the transmission of the primary inhibitory 
neurotransmitter gamma-aminobutyric acid (GABA) or decreasing the activation of the 
primary excitatory N-methyl-D-aspartate (NMDA) receptors (Århem et al. 2003). With 
increasing concentrations of anesthetics, the neurons begin to oscillate between a 
depolarized upstate and a hyperpolarized downstate. If the anesthetic dose rises beyond 
this, the upstate transforms to burst and the downstate becomes longer. These changes 
are seen in EEG when the low-voltage and high-frequency EEG pattern (typical of 
wakefulness) becomes a slow-wave and finally a burst-suppression pattern. (Alkire et 
al. 2008).  
 
 
2.1.1. Gamma-amino butyric acid, GABA 
 
 
GABA is the main inhibitory neurotransmitter in the mammalian central nervous 
system. Its fast inhibitory effects are mediated mainly through the inotropic GABAA 
receptors. Of the general anesthetics, barbiturates, propofol, etomidate, enflurane, 
isoflurane, sevoflurane, and desflurane are GABA agonistic agents (Alkire et al. 2008). 
At clinically effective concentrations, these anesthetics increase the sensitivity of 
receptors to GABA, prolong the inhibitory postsynaptic effect after a GABA release, 
and increase the inhibition of postsynaptic neuronal excitability (Campagna et al. 2003). 
However, the inhibitory effect of some GABAergic agents does not apply to all 
situations, as shown by the proconvulsive effect of enflurane (Rosen, I and Söderberg 
1975) and deep sevoflurane anesthesia (Jääskeläinen et al. 2003). Deep anesthesia, 
combined with hyperventilation and hypocapnia, has been reported to elicit seizures 
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with both enflurane and sevoflurane (Rosen, I and Söderberg 1975, Yli-Hankala et al. 
1999).  
 
 
2.1.2. N-methyl-D-aspartate, NMDA 
 
 
The major excitatory neurotransmitter in the central nervous system is glutamate, which 
produces neuronal excitation through glutamate receptors. The NMDA receptor is 
probably the most widely studied glutamate receptor subtype, and inhibition of NMDA 
receptors is important for the anesthetic effects of ketamine, xenon, and nitrous oxide 
(N2O) (Franks and Lieb 1997, Campagna et al. 2003, Evers and Crowder 2009). EEG-
based depth-of-anesthesia monitors perform well with GABA agonists, but are not 
reliable with those acting via NMDA receptors (Hans et al. 2005, Maksimow et al. 
2006, Park et al. 2006). 
 
 
2.1.3. α2 –adrenoreceptor agonists 
 
 
Although most anesthetics act via GABAergic or glutamatergic transmitter systems, 
there are also selective α2-adrenoreceptor agonists, like dexmedetomidine, that induce 
hypnosis and analgesia, and these are used as sedative agents in ICU (Scheinin and 
Schwinn 1992). 
 
 
2.2. Awareness and recall during general anesthesia 
 
 
2.2.1. History 
 
 
The invention of general anesthesia over 160 years ago was a turning point in the field 
of surgery. General anesthesia is defined as a state of drug-induced unconsciousness 
during which the patients neither consciously perceive nor recall noxious stimulation 
(Prys-Roberts 1987). Hypnosis, analgesia, and immobility with amnesia characterize 
modern balanced anesthesia.  
 
During the early years of general anesthesia a major concern was excessively deep 
anesthesia and its fatal consequences. This situation arose because a single anesthetic 
agent had to attend to all of the components of general anesthesia. Since the first public 
demonstration of ether-anesthesia in 1846 by William Morton, there have also been 
reports about awareness and recall (hereafter merely “awareness”) during general 
anesthesia (Ghoneim 2001). Awareness during anesthesia implies that patients are 
aroused by stimuli, leading to memory storage for future explicit recall (Ghoneim 
2001). Traumatic awareness during general anesthesia became a problem after the 
introduction of curare as a muscle relaxant in 1942 (Griffith and Johnsson 1942). 
Winterbottom (1950) published the first case report of awareness related to use of 
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neuromuscular blocking agents (NMBAs) in 1950 and opened the gate for studies in 
this area. 
 
 
2.2.2. Incidence and risk factors 
 
 
Awareness is a rare adverse consequence of general anesthesia. Since the 1960s, when 
the first studies were published, the incidence of this complication has declined from 
1.2% to 0.1% (Hutchinson 1960, Brice et al. 1970, Ranta et al. 1998, Sandin et al. 2000, 
Myles et al. 2004, Sebel et al. 2004, Ghoneim et al. 2009). Higher incidence of 
awareness (0.8-1.2%) among children than adults has been reported (Davidson et al. 
2005a, Lopez et al. 2007). However, in certain adult patient groups, such as those 
undergoing anesthesia for cardiac, emergency trauma, or obstetric surgery, an increased 
risk for awareness has been described (Ghoneim and Block 1992, Ghoneim et al. 2009). 
Several factors increase the risk of awareness, including light anesthesia, a history of 
awareness, chronic use of central nervous system depressants, use of NMBAs during 
surgery, female sex, increased American Society of Anesthesiologists (ASA) physical 
status, younger age, smaller dose of primary anesthetic, inadequate or misused 
anesthesia delivery systems, and ignoring the use of EEG monitors when the risk is 
otherwise increased (Ghoneim and Block 1992, Ranta et al. 1998, Ekman et al. 2004, 
Myles et al. 2004, Sebel et al. 2004, Ghoneim et al. 2009).  
 
In a meta-analysis, Ghoneim and colleagues (2009) compared the data of 271 cases of 
awareness published for the period 1950-2005 with the data of 19 504 patients without 
awareness. Overly light anesthesia was found to be the most common cause of 
awareness. Among the patients with awareness, no volatile anesthetic agents or propofol 
was used during the maintenance of anesthesia in 23% of cases. There was no 
difference in the use of N2O between patients with and without awareness. Ranta and 
colleagues (1998) showed that patients with awareness received less propofol and 
isoflurane during surgery than patients without awareness.  
 
Based on the existing literature, a complete muscle paralysis had been thought to be a 
significant risk factor for awareness during general anesthesia. There are no randomized 
controlled trials, but in the study of Sandin and colleagues (2000), the authors reported 
that the incidence of awareness was 0.1% without the use of muscle relaxants, doubling 
when they were used. Although Ghoneim and colleagues (2009) found no difference in 
the use of NMBAs between the patients with and without awareness, they 
recommended avoiding unnecessary use of NMBAs to avoid total paralysis.  
 
Several studies have indicated that females are at increased risk of awareness (Ranta et 
al. 1997, Ghoneim et al. 2009). In the studies of Buchanan et al. (2006) and Gan et al. 
(1999) women recovered from anesthesia faster than men despite similar amounts of 
anesthetic drugs per kilogram weight administered. These findings suggest that females 
might be less sensitive to the central nervous system effects of anesthetics than males 
(Ghoneim et al. 2009).  
 
In outpatient surgery, one of the main goals is to conduct operative procedures cost-
effectively. This puts pressure on reducing operating theater change-over times and 
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length of stay in the recovery room, thus necessitating the use of short-acting 
anesthetics. This might increase the risk of awareness in outpatient anesthesia. 
However, upon interviewing 5216 ambulatory surgery patients, Enlund and Hassan 
(2002)  detected no cases of awareness.  
 
 
2.2.3. Classification of awareness 
 
 
Awareness during general anesthesia contains consciousness and memories about 
intraoperative events (Jones 2000). Memory about intraoperative events can be divided 
into explicit (controlled, conscious) and implicit (automatic, unconscious) components 
(Hadzidiakos et al. 2009). Explicit memory means that a patient can recall 
intraoperative events or sensations also in a structured postoperative interview.  
 
To establish the patients’ reports of memories, it is a current norm that an independent 
group of referees judges all reported recollections and defines them as “definite”, 
“probable / possible”, or “no awareness” cases (Ghoneim 2007). Cases of awareness are 
described as definite or clear when patients have explicit recall of intraoperative events 
and as probable, possible, or doubtful when patients have unclear memories or dreams 
that might be related to intraoperative events (Ranta et al. 1998). The Michigan 
Awareness Classification Instrument was recently developed to decrease interobserver 
variability and facilitate the study of intraoperative awareness. It describes class 0: no 
awareness, class 1: isolated auditory perceptions, class 2: tactile perceptions, class 3: 
pain, class 4: paralysis, and class 5: paralysis and pain (Mashour et al. 2010). 
 
In the study of Myles and colleagues (2004), the number of possible cases of awareness 
was double the number of confirmed cases. Dreaming is detected more often than 
awareness (Ghoneim and Block 1992). Myles et al. (2004) reported that 5% of 
bispectral index (BIS)-guided and 7% of routine care patients recalled dreaming during 
general anesthesia. Ranta and colleagues (1998) showed that women reported dreams 
significantly more often than men (14% vs. 9%).  
 
 
2.2.4. Assessment of awareness 
 
 
Assessment of awareness is always based on patients’ subjective reports. Most of the 
incidence studies have been done with a structured interview, which was first described 
by Brice and colleagues in 1970 and later modified by Liu and colleagues (Liu, WH et 
al. 1991). The original questionnaire consists of four questions:  
 
1. What was the last thing you remember before you went to sleep? 
2. What was the first thing you remember when you woke up? 
3. Can you remember anything in between these periods? 
4. Did you dream during your operation?  
(Brice et al. 1970). 
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It is accepted nowadays that more than one interview is needed. Several studies suggest 
that patients who might not remember awareness immediately after surgery may recall it 
later (Macleod and Maycock 1992, Sandin et al. 2000, Ghoneim et al. 2009). In a study 
of Sandin and colleagues (2000), recall of intraoperative events was delayed by several 
days in up to 50% of patients with awareness. Ghoneim and colleagues (2009)  found 
that 37% of patients with awareness reported their memories for the first time more than 
one week after the surgery. 
 
Hearing of voices seems to be the most commonly reported experience during 
awareness, reported in 30-89% of the awareness cases. Tactile perceptions have been 
described in 25-72%, and paralysis or sensation of weakness in 17-85% of cases 
(Moerman et al. 1993, Domino et al. 1999, Samuelsson et al. 2007, Ghoneim et al. 
2009). In a closed claims analysis, pain was experienced by 21% of patients with 
awareness (Domino et al. 1999). In the studies of Samuelsson et al. (2007), and 
Ghoneim et al.  (2009), 46% and 38% of patients with awareness, respectively, 
experienced pain.   
 
 
2.2.6. After-effects of awareness 
 
 
In a long-term follow-up, up to 50 % of patients experiencing awareness developed late 
severe psychiatric sequelae (Lennmarken et al. 2002, Samuelsson et al. 2007). The 
symptoms of these patients fulfill the diagnostic criteria of posttraumatic stress disorder. 
Typical symptoms after awareness are irritability, insomnia, nightmares, anxiety, 
depression, preoccupation with death, and fear of hospitals or future surgery (Blacher 
1984, Ghoneim et al. 2009). Despite its infrequent occurrence, awareness under general 
anesthesia worries patients (Myles et al. 2000). In the study of McClean and Cooper 
(1990), over 50% of patients were afraid of the possibility of not being unconscious 
under general anesthesia when they were preoperatively interviewed. Even after having 
an uneventful and “nonawareness” surgery under general anesthesia, 25% of the same 
patients were still worried about not being asleep during future anesthesia (McCleane 
and Cooper 1990).   
 
 
2.3. Methods for monitoring the depth of general anesthesia 
 
 
2.3.1. Clinical signs 
 
 
Traditionally, the judgment of inadequate general anesthesia has been based on clinical 
signs such as tachycardia, hypertension, sweating, pupillary dilatation, and lacrimation. 
However, signs of increased autonomic activity have not been associated with all cases 
of awareness, and they may also be absent due to use of opioids, cholinergic- and beta-
adrenergic antagonists, vasodilators, and antihypertensive drugs (Ghoneim and Block 
1992, Moerman et al. 1993, Domino et al. 1999), and are therefore inadequate to 
measure the depth of general anesthesia. Movements and breathing pattern may reflect 
the depth of anesthesia, but are not valid when NMBAs are used. The studies of Sandin 
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and colleagues (2000) and Sebel and colleagues (2004) have also shown that avoidance 
of muscle relaxants does not guarantee the avoidance of awareness.  
 
 
2.3.2. Minimal alveolar concentration and isolated forearm technique 
 
 
To prevent awareness, volatile-based anesthesia should be delivered at a concentration 
of at least 0.5 minimal alveolar concentration (MAC) (Chortkoff et al. 1995). The 
isolated forearm technique can be used to evaluate the depth of anesthesia even when 
NMBAs are used. In this technique, a tourniquet is applied to the forearm and inflated 
to above the level of arterial pressure before NMBA is administered. The forearm is 
thus not paralyzed, and the patient may move the arm if the anesthesia is insufficient 
(Tunstall 1977, Russell 2006). However, in the study of Bogod and colleagues (1990), 
the isolated forearm technique seemed to be an unhelpful indicator of awareness. 
Patients under general anesthesia can apparently even carry on conversations using hand 
signals and still have no postoperative recollections (Russell and Wang 1997). 
 
 
2.3.3. EEG-based indices and monitors and auditory evoked potential  
 
 
The interpretation of EEG requires special expertise and is therefore not suitable for 
routine monitoring during general anesthesia. Depth-of-anesthesia monitors, which are 
based on processed EEG signals and other biosignals (e.g. EMG), have been developed. 
These monitors include Bispectral Index Scale (BIS, Aspect Medical Systems, 
Norwood, MA, USA) (Rampil 1998), Narcotrend (MonitorTechnik, Bad Branstedt, 
Germany) (Kreuer et al. 2004), Patient State Index (Physiometrix Inc., North Billerica, 
MA,USA) (Prichep et al. 2004), Cerebral State Index (Danmeter, Odense, Denmark) 
(Cortinez et al. 2007), and Entropy (GE Healthcare, Helsinki, Finland) (Viertiö-Oja et 
al. 2004). Middle latency auditory evoked potential (MLAEP, A-line AEP monitor, 
Danmeter, Odense, Denmark), has also been widely studied and has proven to be a 
useful indicator of the depth of anesthesia, especially when light anesthesia is used 
(Thornton et al. 1989).  
 
 
2.4. Measurements of analgesia during general anesthesia 
 
 
Analgesia means “no pain” (Greek algos = pain; an = no). Pain is a subjective 
experience evoked by internal or external stimuli. Subjective perception of pain is not 
dependent on but may be caused by external stimuli. During general anesthesia the 
conscious experience of pain vanishes, although the reaction to painful surgical stimulus 
is reflected in a surgery-associated stress response. During surgery, the stress response 
is an unconscious systemic reaction to tissue injury that reflects autonomic, hormonal, 
and metabolic changes evoked by noxious stimulation (Desborough 2000). Prolonged 
surgical stress during anesthesia may cause biochemical bodily reactions, which may 
lead to increased morbidity and delayed postoperative recovery (Kehlet 1997). 
Intraoperative nociception due to improper surgical analgesia leads to measurable 
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reactions to noxious stimuli (Korhonen and Yli-Hankala 2009). Suppression of pain 
signaling pathways leads to antinociception and reduces stress responses. Here surgical 
stress refers to the balance between nociception and antinociception during surgery. 
 
Several methods, including heart rate variability (Guignard 2006), suppression of 
photoplethysmographic pulse wave amplitude (Seitsonen et al. 2005, Rantanen et al. 
2006), activation of facial muscles (Hynynen et al. 1985, Takamatsu et al. 2006), 
changes in skin conductivity (Storm et al. 2002), pupillometry (Larson et al. 1997), 
ocular microtremor (Kevin et al. 2002), and EEG-based monitoring (Takamatsu et al. 
2006) have been proposed to assess the balance between nociception and 
antinociception.  
 
 
2.4.1. Autonomic reactions  
 
 
Clinically observed autonomic reactions, such as changes in breathing rate and volume, 
hypertension, tachycardia, sweating, lacrimation, and tearing, have been considered to 
indicate inadequate anesthesia (Guignard 2006). A method to standardize the measures 
of autonomic reactions has been proposed by Evans; this involves generating a PRST 
score (pressure, rate, sweating, tears) derived from measures of blood pressure, heart 
rate (HR), sweating, and tears to assess responsiveness (Evans et al. 1987, Guignard 
2006). Of these signs, HR has been shown to be less consistent than blood pressure in 
its relation to nociception (Guignard 2006). The lack of motor response after painful 
stimuli does not predict the ability of an agent to affect blood pressure and HR (Zbinden 
et al. 1994).  
 
 
2.4.2. Photoplethysmography (PPG) 
 
 
Photoplethysmography (PPG), i.e. pulse oximetry, is primarily used to produce an 
estimation of the relative concentration of oxyhemoglobin in blood. PPG measures the 
intensity of transmitted or reflected light of a specific wavelength in order to monitor 
changes in the volume of the light-absorbing structure. A PPG waveform resembles that 
of arterial blood pressure. PPG is related to volume changes and contains information 
about the peripheral blood circulation, including skin vasomotion. Skin vasomotion is 
controlled by the sympathetic nervous system, which is activated during surgical stress. 
The amplitude of the PPG waveform correlates with perfusion and reflects the interplay 
of the left ventricular volume and the capacitance of the vasculature (Murray and Foster 
1996, Korhonen and Yli-Hankala 2009). Changes in PPG amplitude (PPGA) reflect 
changes in the peripheral vascular bed, controlled by the sympathetic nervous system 
(Korhonen and Yli-Hankala 2009). Increased PPGA response (Luginbühl et al. 2002) 
and skin vasomotor response (Shimoda et al. 1998) have been associated with 
nociception during general anesthesia. In a review by Murray and Foster (1996), 
interpretation of the PPG in clinical monitoring is thoroughly discussed.  
 
Several factors may cause artifacts in PPGA measurement. Movement of the probe 
(reflex or passive movement of the patient, coughing, tremor, train-of-four stimulus in 
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the measurement hand), physiological factors (hypothermia, hypovolemia, changing 
circulatory conditions), and pharmacological factors (anesthetics, analgesics, vasoactive 
drugs) may all have an effect on PPGA (Allen 2007, Korhonen and Yli-Hankala 2009). 
 
Seitsonen and colleagues (2005) evaluated the relationship between motor reactions and 
physiological variables during skin incision. The normalized values of movers and 
nonmovers after incision were compared. The authors found that the best classification 
performance was achieved when Response Entropy (RE), RR interval (time between 
two successive beats in ECG), and PPG notch amplitude were combined. The 
classification performance of any single variable alone was considerably worse. 
Luginbühl et al. (2002) found that an absent skin vasomotor reflex (SVmR) does not 
predict a blunted arterial pressure or HR response to tracheal intubation and concluded 
that a decrease of pulse wave amplitude may be a better predictor of hemodynamic 
response.  
 
 
2.4.3. Surgical Stress Index (SSI), Surgical Pleth Index (SPI)  
 
 
Huiku and colleagues (2007) described the development of a Surgical Stress Index 
(SSI), later Surgical Pleth Index (SPI, GE Healthcare Finland Oy, Helsinki, Finland), 
based on the idea of creating a simple numerical measure of surgical stress level in 
anesthetized patients. SSI indicates the balance between intensity of surgical stimulation 
and the level of antinociception (opioid analgesia or neural blockade). SSI uses two 
continuous cardiovascular variables, both obtained from PPG waveforms of the 
peripheral oxygen saturation (SpO2): the interval between successive hearts beats (HBI) 
and PPGA. When additional components were added to the algorithm, the reliability of 
the index was not increased further (Huiku et al. 2007).  
 
To compensate for interindividual variability and intraindividual confounding factors 
(Allen 2007, Korhonen and Yli-Hankala 2009), a normalization with a histogram 
transformation was performed, decreasing the variability in HBI and PPGA not 
associated with surgical stress. If the distribution of a parameter is known, the 
transformation of the parameter results in the percentage of the measured values being 
smaller than or equal to the transformed value. The normalized indices range from 0 to 
100 in all patients regardless of the distribution of the original parameter. A value of 50 
represents an estimate of the average value of the particular parameter in an individual 
patient. SSI is calculated as follows: 100 - (0.7 x PPGAnorm + 0.3 x HBInorm). SSI 
values near 100 correspond to a high stress level, and values near zero to a low stress 
level. Huiku and colleagues (Huiku et al. 2007) have described the calculation of SSI in 
detail.  
 
SSI correlated positively with the intensity of painful stimuli and negatively with the 
remifentanil concentration (Huiku et al. 2007). The study of Ahonen et al. (2007), was 
among the first concerning SSI as a measure of nociception/antinociception balance. 
The patients underwent general anesthesia maintained with a desflurane-N2O-
remifentanil or desflurane-N2O-esmolol combination. RE and SE were targeted to 40 in 
both groups, and the infusions of remifentanil and esmolol were adjusted to maintain a 
stable hemodynamic state. During skin incision SSI increased in the esmolol group, but 
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not in the remifentanil group. SSI increased in both groups after the insertion of 
troacars, but stayed lower in the remifentanil group than in the esmolol group. Two 
patients in the esmolol group, but none in the remifentanil group, moved during the 
surgery.  
 
Struys and colleagues (2007) found that during painful stimuli SSI correlated better 
with remifentanil concentration than SE, RE, PPGA, and HR, and was independent of 
propofol concentration, in contrast to Entropy indices.  
 
 
2.5. EEG and quantitative EEG-derived indices 
 
 
2.5.1. EEG during general anesthesia 
 
 
German psychiatrist Hans Berger published the first systematic report of electrical 
signals recorded from the human scalp in 1929. He showed that electrical activity of the 
cortex differs between sleep and wakefulness compared with electrical activity in 
epilepsy (Berger 1929).  
 
To monitor the effect of anesthetic agents, electrical signals from the cerebral cortex 
have been used. Routine clinical EEG measures voltage changes in the time domain 
with scalp electrodes. As the measured voltage differences are very small, amplifiers are 
needed to expand the voltage differences between surface electrodes attached to the 
scalp. During general anesthesia, EEG may also be used to monitor oxygen delivery to 
the brain and metabolic suppression of the cortex (Rampil 1998).  
 
EEG signal has a wide frequency spectrum, ranging from 0 to 100 Hz (Martin 1991). 
The frequency bands used to classify EEG activity are delta (δ) < 3.5 Hz, theta (θ) 4-7.5 
Hz, alpha (α) 8-13 Hz, and beta (β) >13 Hz (Niedermeyer 1998). 
 
EEG during awareness is associated with desynchronized, low-voltage, and high- 
frequency patterns. In healthy adults, α-activity is a typical pattern in relaxed 
wakefulness with eyes closed. β-activity is associated with mental activity and attention. 
In healthy adults, δ-waves are seen only in sleep and also θ-activity increases in 
drowsiness and sleep. Fast gamma frequencies can be seen after administration of 
ketamine and N20 (Freye and Levy 2005). Depression of consciousness with rising 
anesthetic doses eventually leads to slower EEG patterns with increased cortical 
synchrony (Rampil 1998). 
 
Stockard and Bickford (1975) originally described the effect of a deepening level of 
anesthesia on EEG as follows: 
1. Disorganized high-frequency activity (α- and β-activity) 
2. Organized activity with an increase in rhythmicity and voltage (θ- and 
-activity) 
3. Mixtures of slower (θ and ) and faster frequencies (β) and at deeper 
levels increased delta activity 
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4. Burst suppression (with the duration of suppression becoming longer 
with deeper levels) 
5. Suppression, inactive EEG  
 
Several other biosignals are also present on the scalp. Electrocardiogram (ECG), EMG, 
and electroculogram may interfere with the EEG signal (Rampil 1998). Originally, the 
use of EEG as a measure of the depth of anesthesia was in the hopes of defining the 
anesthetic state with the reference to the EEG pattern regardless of the anesthetic agent 
used. However, different anesthetic agents and their combined use may cause variable 
changes to the EEG pattern (Clark and Rosner 1973). The anesthetics that produce both 
excitation and inhibition (e.g. diethyl ether, cyclopropane, sevoflurane) may cause an 
EEG pattern with generalized epileptiform activity (Vakkuri et al. 2000, Freye and Levy 
2005). Ketamine induces an increase in fast γ-activity (40-60 Hz) of EEG, which may 
play a role in its CNS-stimulating effect (Hering et al. 1994, Maksimow et al. 2006).  
 
 
2.5.2. Quantitative EEG-derived indices 
 
 
Power spectral analysis is a standard method for quantification of the EEG. Power 
spectrum reflects the amount of activity in different frequency bands of the EEG signal. 
For power spectral analysis, EEG is digitized and Fast Fourier Transformation (FFT) is 
used to transform the time domain EEG to the frequency domain. Results of the FFT 
analysis display the EEG signal content as amplitude of power vs. frequency histogram 
without reducing the information within the EEG waveform. Several quantitative EEG 
(qEEG) variables have been calculated with FFT: absolute and relative power of each 
frequency band, total power of EEG, and median and spectral edge frequency (Rampil 
1998). 
 
Different methods to process the original EEG signal have been evaluated for the 
monitoring of the depth of anesthesia. These monitors utilize mathematically processed 
data from one or two EEG channels (including also other biosignals, such as EMG), 
measured from the forehead of the patient, and if simplified, use the loss of high 
frequencies and shift to low frequencies, as a measure of anesthetic drug action (Voss 
and Sleigh 2007). A single index most often ranging from zero to 100 is produced from 
several variables as a surrogate of the depth of anesthesia. Usually, a low index value 
indicates deep anesthesia and a high value alertness. As a measure of hypnosis during 
anesthesia, BIS (Glass et al. 1997), Entropy (Vakkuri et al. 2004), and AEP monitors 
(Struys et al. 2002) have gained acceptance. Despite their increasing popularity, the 
reliability and cost benefit of these monitors are still under debate (Bruhn et al. 2006).  
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2.5.3. Bispectral Index Scale (BIS) 
 
 
Development and principles of BIS 
 
 
In the 1960s, bispectral analysis was introduced in connection with ocean wave motion, 
atmospheric pressure changes, seismic activity, and sunspots by geophysists (Sigl and 
Chamoun 1994).  Barnett et al. (1971) and Dumermuth et al. (1971) were the first to 
apply bispectral analysis to EEG signals in 1971 and described it in awake and sleeping 
subjects. Signal processing with bispectral analysis is capable of detecting and 
quantifying both linear and nonlinear signals, and is therefore suitable for quantifying 
subtle changes in brain electrical activity (Freye and Levy 2005). The BIS algorithm 
uses derivatives from conventional EEG and EMG power spectral analysis and elements 
of bispectral analysis, and measures the state of brain activity in relation to the depth of 
anesthesia (Sigl and Chamoun 1994). The BIS index is a result of a multivariate logistic 
regression analysis from a prospectively collected database of EEG recordings from 
anesthetized adult volunteers with behavioral assessments, clinically important 
endpoints, and hypnotic drug concentrations. The thorough review of Rampil (1998) 
outlines the principles of development and mode of action of BIS.  
 
During general anesthesia BIS reflects the four following EEG components: the low- 
frequency feature during deep anesthesia, the high-frequency feature with beta-
activation in a light anesthesia, the burst suppression ratio (BSR), and the degree of 
suppression. It is a weighted sum of EEG variables derived from the time domain, 
frequency domain, and bispectral domain. The degree of burst suppression is calculated 
from the time domain with two algorithms: BSR and “QUAZI”. QUAZI improves burst 
suppression detection in the presence of a wandering baseline by incorporating 
information about low frequency power. A variable called BetaRatio is derived from the 
frequency bands of 30-47 Hz and 11-20 Hz, and a variable called SynchFastSlow is 
derived from the bispectral domain component of the epoch in the areas of the 
bifrequency plane defined by 40-47 and 0.5-47 Hz. BSR indicates the fraction of epoch 
length where the EEG voltage does not exceed 5 μV. (Rampil 1998). 
 
 
Hypnotic titration and BIS 
 
 
BIS creates a dimensionless number, scaled from 100 to zero, which reflects the depth 
of anesthesia; 100 represents an alert and orientated state, and zero complete electrical 
silence of the cerebral cortex (inactive EEG). FDA approved BIS for the monitoring of 
the anesthetic effect in 1996, and since 1997 BIS (Aspect Medical Systems Inc., 
Norwood, MA, USA) has been in clinical use. BIS was originally approved only for the 
monitoring of hypnosis, but has since then received an indication of reducing the 
incidence of intraoperative awareness during general anesthesia (FDA 2004) (Johansen 
2006). BIS indices from 50 to 60 have been associated with low probability of response 
to verbal command, and indices between 45 and 60 indicate with a high probability 
unconsciousness of the patient. 
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Previous studies have documented that the use of BIS monitoring is connected to a 
reduction of the incidence of awareness (Ekman et al. 2004, Myles et al. 2004), a 
reduction of hypnotic drug administration (Gan et al. 1997), a faster recovery from 
anesthesia (Gan et al. 1997, Johansen and Sebel 2000), and a reduction of postoperative 
vomiting (Nelskylä et al. 2001). BIS cannot predict exactly when a patient’s 
consciousness will return after general anesthesia. Neither does BIS predict a patient’s 
movements or hemodynamic responses to surgical stimuli during general anesthesia 
(Johansen and Sebel 2000).  
 
 
Awareness and BIS 
 
 
Use of the BIS monitor has been shown to reduce the incidence of awareness during 
general anesthesia in both high-risk patients (Myles et al. 2004) and a mixed patient 
pool (Ekman et al. 2004). In a prospective cohort trial of 4945 patients (and 7826 
historical controls), BIS monitoring reduced the incidence of awareness from 0.18% to 
0.04%. The two patients with explicit recall in the BIS monitored group showed 
intraoperative BIS values above 60 (Ekman et al. 2004). In a prospective, randomized, 
multicenter study, Myles and colleagues (2004) studied 2463 patients at high risk of 
awareness (e.g. cardiac surgery, trauma surgery, Cesarean section). In their BIS guided 
group (targeted between 40 and 60), the incidences of awareness and recall were 82% 
lower than in randomized controls in the routine care group (2 patients vs. 11 patients). 
The number that needed to be treated in this population of high-risk patients was 138.  
 
In some studies, no difference in the incidence of awareness between BIS guided and 
routine care patients exists (Sebel et al. 2004, Avidan et al. 2008). Avidan et al. (2008) 
randomized 967 patients into a BIS monitored group and 974 patients into an end-tidal 
anesthetic agent concentration monitored group. All patients were required to be at high 
risk for awareness. In addition to no statistical difference in the incidence of awareness 
between the groups, the use of BIS monitoring was not associated with reduced 
administration of volatile anesthetics (Avidan et al. 2008).  
 
 
Other applications of BIS 
 
 
A reduction of 9-43% in consumption of propofol, related to use of BIS, has been 
reported (Luginbühl et al. 2003, Gurses et al. 2004). Results on consumption of 
sevoflurane and desflurane are contradictory. A significant reduction of 20-30% in 
consumption of sevoflurane and desflurane has been described in some studies (Yli-
Hankala et al. 1999, White et al. 2004) while others indicate no reduction (Luginbühl et 
al. 2003, Bruhn et al. 2005). A meta-analysis by Liu and colleagues (Liu, SS 2004) 
showed a decrease of 19% in all hypnotics if BIS was used during ambulatory 
anesthesia.  
 
To date, BIS has also been applied to or at least evaluated for the uses other than those 
originally approved. It has been studied in pediatric anesthesia (Davidson et al. 2004, 
Klockars et al. 2006), detection of brain death (Vivien et al. 2002) and prediction of 
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neurological outcome after neurological trauma and cerebral ischemia (Fabregas et al. 
2004). It has also been investigated as a monitor of sedation level in the ICU (Shapiro 
1999). Renna and colleagues (Renna et al. 2003) reported that patients with dementia 
(caused by Alzheimer disease or multiple infarcts) had lower than normal “awake” BIS, 
and the index readings correlated with the Mini-Mental State Test.  
 
In conclusion BIS seems to perform best as a reliable depth-of-anesthesia monitor 
during propofol anesthesia. It has some limitations during sevoflurane and enflurane 
anesthesia and does not perform at all with single agent hypnotic techniques with 
ketamine, dexmedetomidine, N2O, and xenon (Johansen 2006). 
 
 
2.5.4. Entropy 
 
 
Background  
 
 
Entropy was defined already in 1948 in the information theory by Shannon (1948a) and 
applied to a power spectrum of a signal in 1984 by Johnson and Shore (1984). When 
used in the context of information theory and signal analysis, entropy reflects 
irregularity, uncertainty, and complexity of a signal (Shannon 1948a, 1948b). As a 
physical idea, entropy is proportional to the logarithm of the number of microstates 
available in a thermodynamic system (Viertiö-Oja et al. 2004). 
 
During deep anesthesia EEG includes only a few frequency components compared with 
the more variable mixture of high, medium, and low frequencies when awake or drowsy 
or with lighter anesthesia. This led to speculation that one method to gauge the depth of 
anesthesia might be to measure the degree of regularity of EEG with an entropy 
algorithm. Pincus (1991) suggested using approximate entropy for the analysis of 
physiological signals in 1991, and Bruhn (2001) applied it to the analysis of EEG. 
Approximate entropy measures the logarithmic likelihood that runs of patterns remain 
similar in the next consecutive period of comparison, and is applicable for short time 
series. However, consecutive EEG epochs are not statistically independent, which 
means that the requirements for approximate entropy calculation are not rigorously met 
(Schwilden 2006).  
 
Spectral entropy originates from a measure of information called Shannon’s entropy 
(Shannon 1948a, 1948b). To obtain spectral entropy, EEG signal is first subjected to 
Fast Fourier transformation to calculate the power spectrum. Shannon’s entropy is then 
applied to the power spectrum to assign a specific value to each frequency present. The 
sum of these values is defined as spectral entropy (Viertiö-Oja et al. 2004). Spectral 
entropy is dependent on sampling frequency and windowing (Rezek 1998), but 
independent of the frequency components of the signal (Viertiö-Oja et al. 2004). During 
general anesthesia both the approximate and the spectral entropy decrease with 
increasing depth of anesthesia (Rezek 1998).  
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Time-frequency balanced spectral entropy 
 
 
M-ENTROPY™ (hereafter Entropy) (GE Healthcare Finland, Helsinki, Finland) is an 
online depth-of-anesthesia monitor based on calculation of spectral entropy. The power 
spectrum is first calculated via Fourier transformation. To calculate the spectral entropy 
of an epoch and frequency range, the power spectrum of the epoch is normalized, so 
that the sum of the normalized power spectrum over the selected frequency range equals 
one. Shannon’s function (Shannon and Weaver 1949) is then applied to the normalized 
power spectrum of the specific frequency range. Finally, the resulting entropy value is 
adjusted between zero and one by dividing by logN, where N represents the number of 
frequency components. Zero corresponds to complete regularity and one to maximal 
irregularity. (Viertiö-Oja et al. 2004).  
 
The original entropy value is subjected to a nonlinear transformation with a monotonous 
spline function to enhance resolution in a clinically interesting level of anesthesia. The 
steepness of the spline function is maximal at the levels of loss of consciousness, during 
a clinically adequate depth of anesthesia, and while a patient is wakening. As a result of 
the spline function, the original spectral entropy ranging from zero to one is changed to 
a scale from zero to 100. For automatic artifact analysis and rejection, each signal is 
sliced to epochs of 0.64 s. Each epoch is observed, and epochs containing artifacts are 
automatically omitted from the final analysis.  
 
The random-appearing EEG signal consists of frequencies between zero and to over 100 
Hz (Martin 1991). The same frequency band also contains artifacts caused by EMG, 
ECG, and electroculogram (Rampil 1998). Changing the time window used to assess 
each frequency component individually optimizes the response time of the Entropy 
algorithm. EEG sampling frequency of 400 Hz is used in the Entropy monitor. For 
frequencies of 32-47 Hz, a time window of 1.92 s is used, and for frequencies of 0-2 Hz 
60.16 s. The time window for frequencies of 2-32 Hz lies between these two extremes. 
Viertiö-Oja et al. (2004) have described the calculation of Entropy index in detail.  
 
 
State Entropy and Response Entropy  
 
 
Entropy collects a 1-channel original biosignal from a patient’s forehead with a self-
adhesive three-electrode Entropy™ -sensor (GE Healthcare Finland, Helsinki, Finland). 
The collected biosignal contains both EMG and EEG signals from the frontotemporal 
region of the head. During anesthesia the total power of the EEG signal remains mainly 
within 0.5-30 Hz (Freye and Levy 2005). However, when an NMDA antagonist is used, 
high-frequency γ-waves of 40-80 Hz are also seen (Maksimow et al. 2006). The EMG 
signal has a distribution from zero to over 200 Hz (Goncharova et al. 2003).  
 
The analysis of the original the EEG results in two numbers: State Entropy (SE) and 
Response Entropy (RE). SE is calculated from frequency bands of 0.8-32 Hz (Viertiö-
Oja et al. 2004), which under general anesthesia consists mainly of EEG, although it 
also includes EMG (Freye and Levy 2005). The time window for calculation of SE is 
between 15 and 60 s. During anesthesia SE reflects primarily the function of cortical 
 28
neurons of the patient. RE is calculated from a frequency band of 0.8-47 Hz. The 
shortest time window for RE calculation is 1.92 s, which is used for entropy calculation 
between frequencies of 32 and 47 Hz, and the longest 15.36 s. Theoretically, SE 
measures EEG activity, and RE provides the combined information of EEG and frontal 
electromyography (fEMG). (Viertiö-Oja et al. 2004). However, it should be noted that 
during voluntary activation the typical frequency of motor units ranges between 5 and 
20 Hz. This means that SE also contains EMG frequencies, although less than RE. 
 
Entropy parameters range from zero (suppression of EEG) to 100 (alert) for RE and 
from zero to 91 for SE. The difference between RE and SE corresponds to the 
contribution from the fEMG-dominated high-frequency band (Viertiö-Oja et al. 2004). 
During general anesthesia fEMG activity may increase because of intensive noxious 
stimuli if analgesia is insufficient or at the end of surgery prior to awakening during 
light anesthesia (Paloheimo 1990). As an advantage for the short window length in the 
frequency band of 32-47 Hz, the algorithm allows fast detection of impending arousal 
related to increased fEMG activity. When no fEMG activity is present, SE and RE are 
equal. The facial muscles have been shown to be more resistant to neuromuscular 
blocking agents (NMBAs) than the muscles of the hand (Paloheimo 1990). In the 
presence of intense noxious stimuli, the facial muscles are activated, even if 80-90% of 
the postjunctional acetylcholine receptors are blocked (Tammisto et al. 1983).  
 
During Entropy monitoring, burst suppression periods are detected with a method 
described in detail by Särkelä et al. (2002). BSR describes the relative amount of 
suppressed EEG within a one-min time window. During burst suppression a one-min 
time window is used for all frequency components of the SE and RE values. Entropy 
detects the suppressed EEG period and considers EEG to be a perfectly regular signal 
with zero entropy. (Viertiö-Oja et al. 2004) 
 
 
Entropy and state of consciousness and unconsciousness 
 
 
Entropy has been shown to be capable of differentiating between the states of 
consciousness and unconsciousness (Schmidt, GN et al. 2004, Vakkuri et al. 2004, 
Takamatsu et al. 2006, White et al. 2006). In the study of Vakkuri and colleagues 
(2004), 70 patients were anesthetized either with propofol, sevoflurane, or thiopental, 
and loss and regaining of consciousness were tested. Sensitivity, specificity, and 
prediction probability (Pk) for consciousness were high, and similar for SE, RE, and 
BIS. Increased RE indicated emergency from anesthesia 11-12 s earlier than SE and 
BIS. 
 
Schmidt et al. compared (2004) Entropy and BIS in 20 patients anesthetized with a 
propofol-remifentanil combination. The authors found that during induction SE, RE, 
and BIS correlated with the OAAS values, but no significant difference in Pk values 
was found between these indices. Pk values of SE, RE, and BIS were high and similar 
also during emergence from anesthesia. White and colleagues (2006) reported similar 
results for SE, RE, and BIS in the detection of consciousness during propofol-
desflurane anesthesia. During the maintenance of anesthesia, all indices responded 
similarly to changes in propofol and desflurane concentrations. The association between 
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SE and regional cerebral blood flow during propofol and sevoflurane anesthesia was 
evaluated in healthy volunteers. Both drugs induced a significant and similar reduction 
in SE and cortical and global cerebral blood flow measured with positron emission 
tomography. (Maksimow et al. 2005). 
 
Dexmedetomidine, a highly selective α2 –adrenoreceptor agonist, is indicated for short-
term sedation of ICU patients. It produces a sleep-like state of sedation that mimics 
normal physiologic sleep. In healthy subjects, dexmedetomidine sedation produced 
EEG activity (sleep spindles) similar to that in normal sleep (Huupponen et al. 2008). 
Dexmedetomidine sedation has been associated with decreased BIS values, comparable 
with those achieved in sedation with propofol (Venn and Grounds 2001). Maksimow 
and colleagues (2007) showed that SE values decreased during dexmedetomidine 
sedation with an increasing dexmedetomidine dose in healthy volunteers. Pk and 
sensitivity values discriminated well between consciousness and unconsciousness. 
 
Laitio and colleagues (2008) studied 17 healthy volunteers to evaluate the performance 
of BIS and Entropy monitors during xenon anesthesia. They found that BIS, SE, and RE 
showed a delay to detect loss of response. However, all indices differentiated between 
conscious and unconscious states with high prediction probability values. No difference 
between these two monitors was found.  
 
 
Entropy and noxious stimuli 
 
 
Vanluchenne and colleagues (2004) investigated the ability of SE, RE, and BIS to 
predict loss of response to verbal command and noxious stimuli. All indices detected 
loss of verbal command accurately, but at 100% sensitivity BIS performed better. 
Sensitivity and specificity for detection of loss of verbal commands decreased for all 
indices along with increased effect-site remifentanil-infusion. None of the indices 
predicted loss of response to noxious stimuli accurately.  
 
Wheeler and colleagues (2005) evaluated the difference between RE and SE by 
subtracting SE values from RE values (RE-SE) caused by fEMG activation during a 
painful stimulation. An increase in the RE-SE as a response to noxious stimuli occurred 
more often in patients anesthetized with 0.8% isoflurane than in patients anesthetized 
with 1.4% isoflurane, and this difference was found with and without NMBAs. 
Increases in HR and mean arterial pressure were connected to an increased RE-SE 
difference. In a study by Takamatsu et al. (2006), 40 patients under sevoflurane 
anesthesia were evaluated. SE and RE were significantly lower in patients who did not 
move in response to electrical stimuli or skin incision. SE, RE, and BIS increased 
significantly with the increasing intensity of electrical stimulation. Tetanic stimuli 
caused an increase in the RE-SE difference, except at 2.5% sevoflurane. However, 
Valjus and colleagues (2006) noted that the RE-SE difference stayed small during 
surgery with both propofol-esmolol and propofol-remifentanil anesthesia. HR, blood 
pressure, and propofol requirement were all increased in the esmolol group relative to 
the remifentanil group. In the esmolol group, every patient moved in response to 
surgical stimuli, in contrast to none of the patients in the remifentanil group. Based on 
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these results, the RE-SE difference seems not to be a reliable measure of the level of 
analgesia. 
 
 
Entropy and consumption of anesthetics 
 
 
A reduced consumption of anesthetics during the general anesthesia related to 
Entropymonitoring has been reported (Vakkuri et al. 2005, Aimé et al. 2006). Vakkuri 
et al. (2005) investigated a total of 368 patients anesthetized with propofol-alfentanil-
nitrous oxide. In the Entropy monitored group, a reduced consumption of propofol and 
hastened early recovery from anesthesia compared with the standard anesthesia group 
were reported. Aimé and colleagues (2006) studied 140 patients undergoing general 
anesthesia with propofol, sevoflurane, and sufentanil. Sevoflurane concentration was 
adjusted according to clinical variables in the control group, and in the BIS and Entropy 
guided groups (either BIS or Entropy, but not both in the same patient) an index value 
of 40-60 was targeted. Patients in the BIS and Entropy guided groups required 29% less 
sevoflurane (p<0.03) than patients in the control group. No difference was found 
between BIS and Entropy monitored groups. Recovery from anesthesia (eye opening, 
tracheal extubation) did not differ between the three groups.  
 
 
Entropy and children 
 
 
EEG changes in children as the brain matures. Since the frequency of the awake 
dominant background activity increases with age, this might have an influence on the 
performance of EEG-based monitors like BIS, which specifically include analysis of 
power–frequency relationships in their algorithm. As Entropy relies on a different 
derivative of the EEG, it is possible that the age-related limitations found with BIS may 
not be seen with entropy (Davidson et al. 2005b). Davidson et al. (2004) demonstrated 
that after awakening from isoflurane-nitrous oxide anesthesia, Entropy was higher than 
during anesthesia for all age groups. Pre-awakening Entropy was higher than Entropy 
during general anesthesia for children (1-12 years). This was not as apparent in infants 
(under 1 year of age). A strong correlation existed between BIS and Entropy for 
children. The correlation was less evident for infants. In two other studies (Davidson et 
al. 2005b, Klockars et al. 2006), children anesthetized with sevoflurane were evaluated. 
BIS and Entropy were inversely related to sevoflurane concentration for children aged 
1-12 years. The changes in these indices were less definite for infants.   
 
To date, only a few studies have dealt with the use of BIS and Entropy monitors in 
children. Previous studies considered BIS and Entropy monitors as suitable tools for the 
measurement of depth of anesthesia in children older than one year, but did not 
recommend them for infants (Davidson et al. 2005b, Klockars et al. 2006) However, 
these monitors have thus far been evaluated only during isoflurane and sevoflurane 
anesthesia. More studies with different anesthetic agents are needed. 
 
 
 31
2.5.5. Artifacts, EEG recording, and their effects on BIS and Entropy monitoring 
 
 
EMG 
 
 
The EMG signal has a wide, noise-like spectrum, which during general anesthesia 
typically dominates at frequencies higher than 30 Hz (Viertiö-Oja et al. 2004), but may 
also exist at frequencies from zero to over 100. Interference from EMG activity has 
been documented to elevate BIS in patients not receiving NMBAs. Vivien and 
colleagues (2003) evaluated 45 ICU patients who were continuously sedated with 
midazolam and sufentanil. BIS and EMG activity decreased significantly following 
administration of NMBAs. In another study, Vivien and colleagues (2002) showed that 
as EMG activity may be present even in brain-dead patients and high BIS values fell 
dramatically when NMBAs were administered, the artifactual increase in BIS can be 
falsely interpreted as cerebral electrical activity. Entropy monitoring and the possible 
artifacts related to this have not been investigated in brain dead patients before the 
present study. 
 
Messner and colleagues (2003) evaluated the effect of EMG activity on BIS. When 
alcuronium and succinylcholine were administered to unanesthetized volunteers (no 
other drugs used), BIS decreased to a minimum of 9 (range 9-64). In a study by Liu et 
al. (Liu, N et al. 2005), patients received target-controlled infusions of propofol and 
remifentanil until loss of consciousness. After loss of consciousness, either a bolus dose 
of atracurium or placebo was administered. In lightly anesthetized patients, 
administration of NMBA decreased BIS and RE, but not SE.  
 
 
Electrical device  
 
 
Electrical appliances may interfere with EEG recording. These interferences may evolve 
from an infusion or motor-driven pump, a mechanical ventilator, a dialysis machine, a 
scan light, or a screen for patient monitoring (Freye and Levy 2005). Electrocautery, an 
atrial pacer, a warming blanket, and an endoscopic shaver have been shown to directly 
affect BIS monitoring (Dahaba 2005). During electrocautery no EEG recording can be 
done with any device because of large artifacts (Freye and Levy 2005). However, the 
hardware of Entropy is claimed to tolerate substantial electrocautery because of 
automatic artifact rejection. During Entropy monitoring a power of frequency range of 
200-1000 kHz is continuously measured, and if electrocautery has affected the EEG 
signal, the epoch will be rejected from further analysis (Viertiö-Oja et al. 2004). White 
et al. (2006) reported that Entropy indices were significantly less influenced by 
electrocauterization during surgery than BIS indices (12% vs. 62%).  
 
During Entropy monitoring the high sampling rate of the EEG signal ensures that sharp 
peaks associated with a pacer (and with electrocardiography, ECG) may be detected and 
removed from the underlying EEG signal (Viertiö-Oja et al. 2004). A power line 
electrical noise of 50-60 Hz may be identified on the original EEG and removed by 
switching off the causative electrical device (Freye and Levy 2005). 
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Biological artifacts 
 
 
Eyelid movements, blinks, muscle activity during swallowing, movements of the body, 
muscle tremor, and sweating are possible causes of biological artifacts during EEG 
monitoring (Freye and Levy 2005). Different clinical conditions, such as hypoglycemia, 
hypovolemia, cerebral ischemia, cardiac arrest, and hypothermia, have an effect on the 
EEG and have been reported to affect BIS readings (Dahaba 2005). Postictal state, 
neurological disorders (Alzheimer, cerebral palsy), old age, and low-voltage EEG 
modify BIS values (Dahaba 2005). 
 
 
2.5.6. Drug effects in EEG (interfering with the use of the derived indices) 
 
 
Ketamine 
 
 
Ketamine is an NMDA antagonist that produces dissociative anesthesia. It has been 
suggested that BIS (Hirota et al. 1999) and Entropy (Hans et al. 2005) cannot reliably 
assess the hypnotic component of anesthesia if racemic ketamine is used. Maksimow et 
al. (2006) evaluated the effects of S-ketamine on EEG in healthy volunteers. SE and RE 
decreased from baseline values during ketamine anesthesia. However, inter- and 
intraindividual variations in SE and RE were high, and their specificity in indicating 
unconsciousness was poor. Compared with propofol, S-ketamine produced more high- 
frequency EEG activity in the gamma band. During ketamine anesthesia the relative 
power of 20-70 Hz EEG activity was associated with high SE and RE indices, and fast 
gamma spindles were detected in visual analysis in all subjects. During propofol 
anesthesia no gamma spindles were detected. Compared with propofol, S-ketamine 
increased the amount of high-frequency EEG activity, while inducing less low- 
frequency activity. The authors suggested, that the differences in these low- and high- 
frequency bands may explain why Entropy is adequate in monitoring the depth of 
propofol anesthesia, but not of ketamine anesthesia (Maksimow et al. 2006). 
 
 
Nitrous oxide 
 
 
Nitrous oxide (N2O) is an NMDA antagonist that produces a sympatholytic effect. A 
paradoxical decrease in the BIS index has been described after discontinuation of N2O. 
This might be related to withdrawal-suppression, which has been described in 
connection with N2O. After sudden discontinuation of N2O, low-frequency - and - 
waves may occur diffusely in EEG (Henrie et al. 1961). This pattern is similar to the 
EEG seen in deep anesthesia. In the study of Rampil and colleagues (1998), different 
concentrations of N2O were administered to healthy volunteers. A change from a higher 
to a lower concentration of N2O produced transient slowing of the EEG signal. At the 
highest concentration of N2O (50% atm), BIS did not differ significantly from baseline 
readings.  
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Sevoflurane 
 
 
Sevoflurane is a short-acting volatile anesthetic that has gained acceptance especially 
for its suitability in mask induction. However, epileptiform activity related to 
sevoflurane anesthesia has been reported in EEG in both healthy adults and children 
(Yli-Hankala et al. 1999, Jääskeläinen et al. 2003) and also in patients with epilepsy 
(Iijima et al. 2000). The epileptiform activity has been related particularly to mask 
induction (Yli-Hankala et al. 1999, Vakkuri et al. 2001) and deep levels of anesthesia 
(1.5-2.0 MAC) (Jääskeläinen 2003). These findings indicate that epileptogenicity of 
sevoflurane might not be associated with changes in the level of anesthesia, instead 
being dependent on the dose of sevoflurane. 
 
In a recent study, Sonkajärvi and colleagues (2009) showed that epileptiform patterns, 
spikes, polyspikes, and periodic epileptiform discharges were found in children 
anesthetized with 8% sevoflurane mask induction. These EEG findings were associated 
with an increase in HR, but no motor activity was noticed. An EEG was recorded with a 
10- to 20-electrode system with a recording band of 0.016-70 Hz. The spikes and 
polyspikes had frontal multifocal maxima and might have been missed had only 
forehead electrodes of EEG-based depth-of-anesthesia monitors been used.  
 
 
2.6. Neuromonitoring in the intensive care unit 
 
 
2.6.1 Noninvasive methods 
 
 
EEG  
 
 
Different EEG characteristics have been related to ischemic brain damage. Suppression 
of EEG (Theilen et al. 2000), lack of EEG reactivity (Gutling et al. 1995), reduced 
alpha variability (Vespa et al. 2002), and generalized epileptiform activity (Young and 
Doig 2005) have been related to poor neurological recovery. However, the significance 
of individual EEG characteristics is partly unclear, as in many studies they have been 
considered only as combined groups of malign or benign phenomena (Wijdicks et al. 
2006). EEG characteristics associated with a poor outcome after cardiopulmonary 
resuscitation seem to include EEG suppression and generalized epileptiform activity 
(Wijdicks et al. 2006), but at which stage of ICU treatment and how soon after 
resuscitation these characteristics indicate poor outcome are unknown.  
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BIS in ICU 
 
 
The Observer’s Assessment of Alertness/Sedation Scale (OAA/S) was used when the 
BIS algorithm was developed, and numerous studies have demonstrated the tight 
correlation between BIS, hypnotic drug concentration, and OAA/S for perioperative 
sedation. These studies suggest that BIS ranging between 65 and 80 is an acceptable 
level of loss of conscious information processing and recall during sedation (Iselin-
Chaves et al. 1998, Kearse et al. 1998, Struys et al. 2003). Good correlations between 
BIS and Sedation Agitation Scale (SAS) (de Wit and Epstein 2003), BIS and Ramsay 
score (Mondello et al. 2002, Riess et al. 2002), BIS and Richmond Agitation-Sedation 
Scale (RASS) (Deogaonkar et al. 2004), and BIS and Glasgow Coma Scale (GCS) 
(Deogaonkar et al. 2004) have been reported during sedation. 
 
Only a few studies have evaluated the ability of BIS to predict the outcome of ICU 
patients. These studies have mostly investigated traumatic head injury or cardiac arrest 
patients. Fabregas et al. (2004) investigated the relation between BIS and the probability 
of recovering consciousness in 25 acute brain-injured patients. Significantly lower BIS 
values were found in brain-injured patients who did not regain consciousness compared 
with those who recovered consciousness. 
 
Myles et al. (2009) investigated the prognostic ability of BIS in unconscious patients 
with severe hypoxic-ischemic brain injury who needed emergency surgery because of 
their head trauma. Clinical examination was performed and BIS recorded before and 
during surgery. An abnormal BIS value (below ten) was indicative of poor neurological 
outcome. The false-positive rate (FPR) was lower for abnormal BIS and absent 
pupillary response than for clinical judgment. However, none of these methods was 
100% specific. Evaluation of prognosis after serious hypoxic-ischemic injury should not 
be based solely on BIS monitoring. 
 
In the recent study of Seder et al. (2009), BIS and suppression ratio (SR) were evaluated 
as predictors of neurological outcome during hypothermia treatment after cardiac arrest. 
BIS and SR of 97 patients were compared with the discharge Cerebral Performance 
Category (CPC). Forty percent were allocated to the good outcome group (CPC 1-2). 
BIS (measured after the first dose of NMBA) was higher in patients with good outcome, 
and BIS below 22 predicted poor outcome. An SR of 48 or more predicted poor 
outcome. BIS and SR predicted outcome better than return of spontaneous circulation 
(ROSC).  
 
 
Entropy for monitoring and sedation 
 
 
Only the two studies concerning Entropy as a sedation monitor in ICU patients have 
been published before the present studies. Walsh et al. (2008) first aimed to assess 
whether Entropy could be used as a measure of sedation level in critically ill patients. 
Thirty mechanically ventilated patients receiving continuous sedation (propofol or 
midazolam) were prospectively evaluated. Entropy monitoring continued up to 72 h. 
The level of consciousness was evaluated every 30 min using a modified Ramsay 
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scoring system. The scoring system was modified to standardize the stimuli by 
including a tetanic stimulus at deep sedation levels. The median SE and RE decreased 
when the Ramsay score increased, but wide variation occurred, especially in the 
Ramsay 4-6 categories. Discrimination between different sedation scores and between 
lighter (Ramsay 1-3) vs. deeper (Ramsay 4-6) sedation ranges was found to be 
inadequate, suggesting inadequate ability to distinguish lighter and deeper sedation from 
each other. A frequent "on-off" effect (entropy values changed rapidly from low to high 
and vice versa) was noticed. This effect was particularly present at deeper sedation 
levels. The on-off effect occurred for both RE and SE, and was associated with fEMG 
activity. High Entropy values during deeper sedation were strongly associated with 
simultaneous high relative fEMG powers. Based on that preliminary study of Entropy as 
a sedation monitor, the authors concluded that Entropy does not discriminate sedation 
state adequately for clinical use in ICU patients. As in most of the BIS-studies, frontal 
EMG activity was found to be a major confounder in clinical sedation ranges.  
 
In the study of Haenggi and colleagues (2009), BIS and Entropy discriminated states 
with very deep, deep to moderate, and no sedation with similar Pk. However, inter- and 
intraindividual variability of Entropy and BIS indices was high. Hence, the authors 
concluded that determination of sedation levels by BIS and Entropy precludes defining 
a target range of values in critically ill patients.  
 
 
Transcranial Doppler ultrasonography  
 
Aaslid and colleagues (1982) introduced Transcranial Doppler ultrasonography (TCD) 
in 1982 as a noninvasive, continuous technique to monitor cerebral blood flow velocity 
in basal cerebral arteries through the intact cranium. TCD is based on a pulsed Doppler 
ultrasonic beam of a frequency of 2 MHz that crosses the skull at “window-points” and 
is then reflected back from the erythrocytes. Temporal, orbital, and foramen magnum 
“windows” can be used to insonate the cerebral arteries. The most commonly used 
artery is the middle cerebral artery (MCA), which is easy to find through the temporal 
window (Moppett and Mahajan 2004). An adequate window is absent in only 8% of 
patients (Itoh et al. 1993). Different analyses of blood flow velocity have been 
conducted. Of the available indices, the pulsatility index (Gosling and King 1974) is 
probably the most frequently used. The pulsatility index normally ranges from 0.6 to 
1.1. It reflects resistance in the distal vessels and elasticity of the vessel wall. HR, 
arterial pressure, vascular compliance, and arterial oxygen and carbon dioxide tension 
may have an influence on the pulsatility index. (Czosnyka et al. 1996, Aggarwal et al. 
2008). 
 
TCD has been used to detect of high-velocity states such as vasospasm or hyperemia. 
Flow velocities more than 120 cm/s in MCA have been considered significantly high 
(Aaslid et al. 1984). High velocity after head trauma is an independent predictor of poor 
outcome (Zurynski et al. 1995). The estimation of intracranial pressure (ICP) and 
cerebral perfusion pressure (CPP) from TCD waveform analysis has been reported to 
correlate with direct ICP and CPP measurements (Sidi and Mahla 1995, Schmidt, EA et 
al. 2001, Aggarwal et al. 2008). Hadani and coworkers (1999) found reduced or absent 
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diastolic flow, reverberant flow, and short systolic spikes in TCD to be related to brain 
death. These authors reported 100% specificity and 96% sensitivity.  
 
 
Other noninvasive neuromonitoring methods 
 
 
Somatosensory evoked potential (SEP) consists of the responses of subcortical and 
cortical neurons to stimulation of peripheral nerve trunks. Bilaterally absent short 
latency SEP (N20) waves to median/ulnar nerve stimulation predict permanent coma 
with a specificity of 100% in patients resuscitated from cardiac arrest, and this is not 
affected by hypothermia treatment (Tiainen et al. 2005). Adults in coma caused by 
hypoxic-ischemic encephalopathy showing absent SEPs have been reported to have less 
than a 1% chance of awakening (Robinson et al. 2003).   
 
Mismatch negativity (MMN) is an automatic event-related brain response to a deviant 
stimulus, alternating with the standard tone. The response has been reported to correlate 
with recovery from the vegetative state after severe brain injury (Wijnen et al. 2007). In 
the prospective study of Fischer and colleagues (2004) with 346 comatose patients 
(caused by stroke, trauma, anoxia, neurosurgery, or encephalitis), the prognostic value 
of late auditory (N100) and cognitive evoked potentials (MMN) were analyzed. After a 
12-month follow-up period, pupillary reflex and N100 proved to be the strongest 
predictive factors for awakening. If also MMN was present, comatose patients never 
moved to a permanent vegetative state. In the later study of Fischer et al. (2006), 62 
comatose patients resuscitated from out-of-hospital cardiac arrest were evaluated. 
Patients with abolished SEP or MLAEP did not regain consciousness (100% 
specificity). All patients in whom MMN was present awakened with 100% specificity. 
Based on these studies, it may be concluded that when MMN is present it predicts 
awakening from coma with a high probability, and nonawakening when MMN and 
pupillary reflex are absent or cortical SEPs are abolished. Further studies comparing 
MMN, SEP, and EEG-derived indices are needed. 
 
Near-infrared spectroscopy (NIRS) estimates the regional changes in cerebral 
oxygenation and is based on the ability of light waves of near-infrared wavelength (700-
1000 nm) to pass through the scalp, skull, and brain to a depth of a few centimeters. 
(Owen-Reece et al. 1999). In head-injured patients, NIRS has been reported to be more 
specific and more sensitive than jugular bulb venous oxygen saturation (SjVO2) 
(Kirkpatrick et al. 1995) and to correlate with cerebral perfusion (Dunham et al. 2002). 
However, the inability of NIRS to distinguish between intra- and extracranial changes in 
blood flow and oxygenation has limited its use in clinical practice (Bhatia and Gupta 
2007a).  
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2.6.2. Invasive methods 
 
 
Intracranial pressure (ICP) 
 
 
ICP is the pressure within the cranial vault relative to atmospheric pressure (Bhatia and 
Gupta 2007b). ICP monitoring is recommended by the European Brain Injury 
Consortium for patients with severe brain injury (Maas et al. 2000). It can be measured 
intraventricularily, intraparenchymally, extradurally, or subdurally. Intraventricular 
catheters allow direct measurement by insertion of a catheter into one of the lateral 
ventricles, and they are considered the “golden standard” of brain monitoring in ICU for 
brain trauma patients (The Brain Trauma Foundation 2000). An average ICP above 25 
mmHg over the whole period of monitoring doubles the risk of death after severe head 
injury (Czosnyka and Pickard 2004).  
 
In neurosurgical units, where ICP is usually monitored, twofold lower mortality has 
been reported compared with general ICUs, where it is not monitored (Patel et al. 
2003). On the other hand, Cremer et al. showed that among survivors beyond 24 h 
following severe brain injury, patients treated with ICP targeted intensive care did not 
have a better outcome than patients treated based on clinical observations and computed 
tomography (CT) findings (Cremer et al. 2005). Robertson et al. (1999) showed a 
decrease in ischemic insults in CPP-oriented therapy, but also an increase in respiratory 
complications compared with ICP-oriented therapy. No difference was found in overall 
neurological outcome between ICP- and CPP-guided groups.  
 
 
Other invasive neuromonitoring methods 
 
 
Venous oxygen saturation in the jugular bulb (SjVO2) provides an estimate of global 
oxygen delivery. It also represents the relationship between cerebral blood flow and 
metabolism, enabling detection of hypo- and hyperperfusion (Dunn et al. 2006). 
However, SjVO2 is a global measure of cerebral oxygenation, and regional ischemia 
may be missed (Gupta 2002). Both abnormally high and low SjVO2 values after 
traumatic brain injury have been associated with poor outcome (Robertson et al. 1995, 
Macmillan et al. 2001). 
 
Thermal diffusion flowmetry is based on the thermal conductivity of cortical tissue, 
which varies proportionally with cerebral blood flow. It has been reported to be more 
sensitive than TCD in detecting reversible vasospasm in patients with subarachnoid 
hemorrhage (Vajkoczy et al. 2001). Laser Doppler flowmetry measures the local 
circulatory blood flow. It has been used to assess autoregulation, carbon dioxide 
reactivity, and responses to therapeutic interventions (Kirkpatrick et al. 1996), and also 
to diagnose ischemia (Kirkpatrick et al. 1994). 
 
Cerebral microdialysis measures the concentration of chemicals (molecules below 20 
kDa) found in the extracellular space of the brain. Substances usually measured are 
energy-related metabolites (glucose, lactate, pyruvate, adenosine, xanthine), 
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neurotransmitters (glutamate, aspartate, -aminobutyric acid), markers of tissue damage 
or inflammation (glycerol, potassium, cytokines), and exogenous substances (drugs) 
(Gupta 2002). Cerebral microdialysis has been used mainly for research purposes. 
However, the consensus meeting on cerebral microdialysis recommended its use in 
brain injury patients, when ICP or CPP monitoring is needed (Hillered et al. 2005).  
 
Measurement of brain tissue oxygenation involves insertion of microsensors into brain 
parenchyma. Commercially available microsensors measure directly brain tissue gases, 
either measuring brain tissue oxygen tension or partial pressures of oxygen, and carbon 
dioxide, or pH (Bhatia and Gupta 2007a). Brain tissue oxygen partial pressure less than 
8-10 mmHg is related to ischemia (Kett-White et al. 2002), brain tissue carbon dioxide 
more than 60 mmHg to increased risk of vasospasm in patients with cerebrovascular 
disease (Charbel et al. 2002), and pH below 7 to increased risk of mortality in head 
injury patients (Gupta et al. 2004). 
 
 
2.6.3 Laboratory parameters 
 
 
Various blood markers have been evaluated for assessing neurological prognosis after 
cardiac arrest. Of these markers, neuron-specific enolase (NSE) and S-100B protein 
have gained acceptance. These markers are not secreted into extracellular fluid by intact 
cells, but are set free after destruction of cells with neuronal differentiation. The 
concentration of these markers in the blood has been assumed to be proportional to the 
extent of hypoxic brain injury after cardiac arrest. NSE is a gamma isomer of glycolytic 
enzyme enolase and is located in the cytoplasm of neurons and cells with endocrine 
differentiation (Schmechel et al. 1978). The high molecular weight of 78 kDa makes 
NSE unlikely to leave the cytoplasm unless brain injury occurs. It is composed of two - 
subunits and has a biological half-life of 24 h. Increased serum NSE levels have been 
reported after cardiac arrest (Rosen, H et al. 2001, Tiainen et al. 2003), stroke 
(Cunningham et al. 1991), and brain injury (Skogseid et al. 1992).  
 
S-100B protein is a calcium-binding protein with two subtypes. The -subtype is 
found in astroglial cells, and the -subtype mainly in astroglial and Schwann cells, but 
has also been demonstrated in some neoplasms and in melanocytes, adipocytes, and 
chondrocytes (Zimmer et al. 1995). The molecular weight of the S-100B protein is 21 
kDa, and its biological half-life of 0.5 h (Jonsson et al. 2000). Increased levels of serum 
protein S-100B have been reported in patients after traumatic brain injury (Elting et al. 
2000), stroke (Missler et al. 1997, Elting et al. 2000), cardiac arrest (Rosen, H et al. 
1998, Tiainen et al. 2003), and cardiac surgery (Jonsson et al. 2001). 
 
Although several studies exists of NSE and S-100B in comatose patients, only a few 
controlled, randomized studies have been done on patients surviving from cardiac arrest 
and treated with mild therapeutic hypothermia. In a substudy of the European 
hypothermia after cardiac arrest (HACA) trial, Tiainen and coworkers (2003) analyzed 
NSE and S-100B values in 34 hypothermia-treated cardiac arrest patients and in 32 
normothermic cardiac arrest patients. They found that the levels of NSE, but not the 
levels of S-100B, were lower in hypothermia-treated patients than in normothermia- 
treated patients. In 88% of the hypothermia-treated patients, NSE decreased between 24 
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and 48 h; the corresponding proportion in normothermia-treated patients was 50%. The 
decrease in NSE values was associated with survival, recovery of consciousness, and 
good neurological outcome. In the study of Tiainen et al., no significant difference was 
present in S-100B values between 24 and 48 h. On the other hand, Hachimi-Idrissi and 
coworkers (2005) found that S-100B decreased significantly between the time of 
admission and at 24 h after cardiac arrest in patients treated with hypothermia. 
 
In the study of Rosen and coworkers (Rosen, H et al. 2001), S-100B peaked already 
within 24 h of cardiac arrest, and levels elevated above 0.217 g/l on day 2 after ROSC 
indicated severe neurological injury and predicted poor outcome with a 100% positive 
predictive value (PPV). In the same study, a serum level of NSE above 23.3 g/l had a 
100% PPV for coma, permanent vegetative state, or death. Zandbergen et al. (2006) 
showed that 60% of patients resuscitated after cardiac arrest had NSE more than 33 g/l 
on day 1 to day 3. All of these patients had a poor neurological outcome. The cut-off 
point for an FPR of zero has been difficult to define, and variation between 20 and 65 
g/l has been reported (Wijdicks et al. 2006). Attempts have also been made to define 
cut-off values for S-100B in the same patient material. Zandberger and coworkers 
(2006) reported the median FPR of zero to be 5%, but in other studies this has ranged 
between zero and 54% (Martens et al. 1998, Rosen, H et al. 1998, Tiainen et al. 2003).  
 
Little research has been performed on survivors of cardiac arrest treated with mild 
therapeutic hypothermia. In addition, the results of the previous studies are partly 
contradictory concerning the cut-off values of blood markers. The present study was 
conducted to evaluate whether blood markers correlate with the EEG-derived indices as 
early prognostic markers after cardiac arrest. 
 
 
2.7. Cardiac arrest and therapeutic hypothermia  
 
 
Cardiac arrest is associated with the loss of cerebral perfusion, which leads to anoxic 
brain injury or post-resuscitation encephalopathy (Maramattom and Wijdicks 2005). 
Most of these patients have a poor prognosis for recovery (Booth et al. 2004). 
Neurological recovery is primarily determined by the extent of hypoxic-ischemic 
encephalopathy that develops during and after circulatory arrest. After ROSC, the 
following reoxygenation may lead to additional inflammatory reactions that can 
continue for several days, leading to the concept of global ischemia-reperfusion injury. 
Techniques directed to minimize the inflammatory response and cell death during the 
reperfusion period may improve the neurological outcome after cardiac arrest (Castren 
et al. 2009). 
 
Based on clinical, randomized trials, therapeutic hypothermia after cardiac arrest has 
been shown to be beneficial with regard to neurological prognosis (Bernard et al. 2002, 
Hypothermia after Cardiac Arrest Study Group 2002). Several studies have shown mild 
(body temperature 32-34ºC) therapeutic hypothermia to be a safe therapy, with only a 
few complications, and it is recommended by the American Heart Association and the 
International Liaison Committee on Resuscitation for comatose survivors of cardiac 
arrest (Nolan et al. 2003, Froehler and Geocadin 2007, Castren et al. 2009). 
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Already in 1944, hypothermia has been reported to decreases cerebral oxygen utilization 
(Field et al. 1944). A linear relationship between temperature decrement, cerebral blood 
flow, and oxygen consumption has been observed down to 25ºC (Ehrlich et al. 2002). 
The beneficial effects of hypothermia also include reductions in the following 
phenomena: apoptotic neuronal cell death (Zhu et al. 2004), intracellular acidosis 
(Chopp et al. 1989), lipid peroxidation (Lei et al. 1994), accumulation of glutamate 
(Takata et al. 2005), release of glycine (Baker et al. 1991), inflammation (Kimura et al. 
2002), and production of nitric oxide and free radicals (Castren et al. 2009). 
Hypothermia treatment has been shown to reduce immediate postischemic 
hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, 
brain edema and neuronal damage after cerebral ischemia (Karibe et al. 1994). The 
International Liaison Committee has recommended that all comatose cardiac arrest 
patients with initial ventricular fibrillation (VF) should receive hypothermia treatment 
for 12-24 h (Nolan et al. 2003).  
 
 
2.8. Nonconvulsive status epilepticus in ICU 
 
 
Status epilepticus is defined as continuous seizure activity lasting at least 30 min, or 
intermittent seizures occurring over a 30-min period without recovery of consciousness 
between each convulsion (Gastaut 1983). It is a life-threatening condition with a one-
month mortality rate of 22% (DeLorenzo et al. 1995). The incidence of status 
epilepticus is approximately 18 to 41 episodes per population of 100 000 per annum in 
the United States (DeLorenzo et al. 1996). This incidence refers to clinically detectable 
episodes of status epilepticus, not incorporating the incidence of nonconvulsive status 
epilepticus (NCSE). NSCE might be the second most common acute neurological 
emergency after vascular accidents (Costello and Cole 2007). NCSE may occur 
independently or visible status may continue subclinically and be evident only in EEG 
recording.  
 
NCSE is a form of the status with no visible seizures and is an often unrecognized cause 
of coma. The definition of NCSE is evolving. Classifications based on clinical 
presentation and underlying pathophysiology have been suggested (Fountain and 
Lothman 1995, Kaplan 1999). NCSE is characterized by behavioral or cognitive change 
from baseline for at least 30 min with EEG evidence of seizures. Diagnosis of NCSE 
cannot be reliably done without multichannel EEG recording. The cognitive changes 
during NCSE may incorrectly be associated with a postictal state, intoxication, 
psychogenic or psychotic states, or even mental retardation (Kaplan 1999).  
 
Towne and colleagues (2000) evaluated the presence of NCSE in 236 comatose patients 
with no clinical signs of seizure activity. EEG monitoring demonstrated that 8% of 
these patients met the criteria for the diagnosis of NCSE. The authors concluded that 
NCSE is an under-recognized cause of coma, and EEG should be included in the routine 
evaluation of comatose patients even if clinical seizure activity is not apparent. In the 
study of Claassen and colleagues (2004), 570 patients with continuous EEG monitoring 
(cEEG) (because of detection of subclinical seizures, evaluation of decreased level of 
consciousness, or titration of antiepileptic drugs) were retrospectively evaluated. 
Seizures were detected in 19% of these patients. Of the seizures, 88% were detected 
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within the first 24 h of monitoring, but in 7% of patients the first seizure was detected 
only after 48 h of monitoring. Young and colleagues (1996) monitored 49 patients with 
cEEG. The overall mortality was 33% (16 of 49). Of the 23 patients with NCSE, 13 
died (mortality 57%). Age, presence of NCSE, seizure duration, hospital and NICU 
length of stay, and delay to diagnosis were variables significantly associated with 
mortality. However, when data were analyzed with multivariate logistic regression, only 
seizure duration and delay to diagnosis were associated with increased mortality. 
 
Oddo and colleagues (2009) studied retrospectively the risk factors and predictive value 
of electroencephalographic seizures and periodic epileptiform discharges in a 
population of 201 medical ICU patients without known acute neurological injury. 
Patients were cEEG-monitored for investigation of possible seizures or changes in 
mental status. Of the patients, 60% had sepsis as the primary admission diagnosis and 
48% were comatose at the time of cEEG. Of these patients, 10% had EEG-detected 
seizures, 17% periodic epileptiform discharges, and 5% both. Seizures were noticeable 
only in cEEG in 67% of patients. Sepsis patients showed higher rates of both seizures 
and periodic epileptiform discharges than patients without sepsis (32% vs. 9%). 
Electroencephalographic seizures or periodic epileptiform discharges were associated 
with poor neurological outcome (death or severe disability) at hospital discharge (89% 
with electroencephalographic seizures or periodic epileptiform discharges vs. 39% 
without). 
 
 
2.9. Monitoring epileptiform EEG and seizures 
 
 
The automatic detection of epileptiform seizures has been studied since the 1970s (Ives 
et al. 1974, Gotman and Gloor 1976). The algorithms to detect the seizures are mainly 
based on identification of epileptiform spikes and special rhythmic EEG patterns 
associated with epileptiform seizures. Gloor (1975) described a spike as a triangular 
transient distinguishable from the rest of the background EEG activity,  and in many 
algorithms the estimation of the relation between the amplitude of the epileptiform 
spike and the amplitude of background activity plays a fundamental role (Gotman 
1982). The methods based on half-wave decomposition (Gotman and Gloor 1976) and 
wavelet transforms (Goeltz et al. 2000, Saab 2005) have been described.   
 
Wavelet entropy has been proposed for the analysis of short-duration EEG signals 
(Rosso et al. 2001). A novel quantitative variable, wavelet subband entropy (WSE), was 
described for characterizing the evolution of the epileptiform EEG waveforms (Särkelä 
et al. 2007). WSE is based on a dyadic multiresolution decomposition of the signal 
performed with a discrete wavelet transform using the Mallat algorithm (Mallat 1989). 
A detailed description of WSE is published in the article of Särkelä and colleagues 
(2007). In this study, EEG data of 60 patients under sevoflurane mask induction were 
investigated. WSE variables were calculated from different frequency bands. The ability 
of the WSE in detecting and quantifying epileptiform EEG activity and also in 
recognizing misleading BIS readings caused by epileptiform activity was evaluated. 
WSE from the frequency bands of 4-16 and 16-32 Hz was found to be sufficient for 
quantifying epileptiform activity. For monophasic pattern monitoring, the lower 
frequency band was used, and for spike activity monitoring, the higher frequency band 
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was used. WSE values of the lower and higher bands followed the time evolution of 
epileptiform activity with prediction probabilities of 0.809 and 0.804. In deep anesthesia 
with epileptiform activity, WSE detected EEG- patterns causing BIS greater than 60, 
with an event sensitivity of 97% (Särkelä 2007). 
 
Although several methods have been evaluated, none of these automatic monitors can 
reliably differentiate all of the spikes caused by artifacts from actual epileptiform 
activity. The original EEG signal always contains artifacts that must be visually 
recognized and excluded before further processing of the EEG signal. However, many 
of the critically ill patients suffer from neurological disturbances, and epileptiform 
activity may go undiagnosed because of inadequate monitoring or a lack of expertise 
with the interpretation of the original EEG signal.  In addition, NCSE and the use of 
NMBAs may complicate the diagnosis of epileptiform activity in the ICU. A 
noninvasive, easy-to-interpret method for neuromonitoring is needed. More studies 
should therefore be conducted to validate WSE in ICU circumstances.  
 
 
2.10. Brain death 
 
 
The Ad Hoc Committee of the Harvard Medical School first defined the concept of 
brain death in 1968 (Ad Hoc Committee of the Harvard Medical School 1968). It 
enabled the function of organs other than the brain to be maintained after death, and 
modern organ transplantation programs were launched. The diagnosis of brain death is 
based on clinical examination showing an absence of both cranial nerve reflexes and 
spontaneous breathing. Various confirmatory tests, demonstrating circulatory arrest or 
loss of electrical activity in the brain, have been used. These include transcranial 
Doppler sonography (TCD), scintigraphy, four-vessel angiography, dynamic computed 
tomography, magnetic resonance imaging, positron emission tomography, EEG, or 
evoked potential testing (Randell 2004). In some European countries, one or all of these 
tests are mandatory, but only conventional angiography is recognized as a reliable 
confirmatory test by all European countries (Haupt and Rudolf 1999). In Finland, brain 
death diagnosis is based on clinical examination, and confirmatory tests are used only 
when the neurological examination and apnea testing are not reliable because of facial 
or thoracic injury or pulmonary disease (Randell 2004). 
 
In the absence of sedatives, the presence of electrocerebral silence in EEG (combined 
with clinical findings) is highly reliable in the diagnosis of brain death. Electrocerebral 
silence is defined to be present when electrical activity is absent at levels higher than 2 
μV with the instrument set at a sensitivity of 1 μV per millimeter for at least 30 min 
(American Electroencephalographic Society 1994). Using high sensitivity of an EEG 
machine increases the visible amount of physiological and nonphysiological artifacts. 
EMG artifacts reflecting remaining motor activity may contaminate EEG recordings, 
and a definite diagnosis for electrocortical silence cannot be made in such situations 
without using NMBAs. Fifteen percent contraction of the frontalis or temporalis 
muscles may produce detectable EMG activity over the entire scalp (Goncharova et al. 
2003).  
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BIS has been tested for its capacity to detect brain death. Escudero et al. (2005) found a 
BIS value of zero and BSR 100 to correlate with physiological and confirmatory 
examinations in confirming brain death. Vivien et al. (2002) showed that all the patients 
with GCS below 5, BIS value zero, and burst suppression 100 were brain-dead, as 
confirmed by physiological status, traditional EEG, and angiography. The authors 
concluded that BIS might be used to detect the onset of brain death in severely 
comatose patients. Misis et al. (2008) retrospectively observed patients, meeting the 
clinical criteria of brain death and organ donation protocol criteria during their ICU 
stay. A gradual decrease in BIS values and an increase in BSR were observed when the 
patient evolved toward brain death. At the time brain death was diagnosed, all patients 
showed BIS zero and BSR 100. The authors concluded that although BIS has not been 
validated for the brain death diagnosis it is a continuous bedside monitoring method that 
can be used to detect the moment of brain death.  
 
EEG and indices derived from it are vulnerable to several artifacts. Entropy has not 
been previously studied in connection with brain death. 
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3. Aims of the study  
 
 
The aim of the study was threefold. First, to evaluate the usefulness and possible 
sources of artifacts of noninvasive depth-of-anesthesia and analgesia monitoring 
methods in the operating theater and in the intensive care unit (ICU) in patient groups in 
which these monitors were not previously studied or validated. Second, to examine the 
incidence of intraoperative awareness and necessity of the depth-of-anesthesia monitors 
in outpatient anesthesia. Third, to evaluate the feasibility of these automatic-monitoring 
methods in the prediction of neurologic recovery in comatose intensive care patients.   
 
Specific objectives were as follows: 
 
1. To evaluate whether the incidence of intraoperative awareness and explicit recall 
during general anesthesia is different in outpatients relative to inpatients (I). 
 
2. To compare the feasibility of BIS and Entropy monitoring in brain-dead organ 
donors during organ retrieval and to determine the sources of the EEG signal 
artifacts that may disturb monitoring with these automatic indices of brain 
function (II). 
 
3. To evaluate whether the SSI (SPI) levels differ in patients undergoing the same 
type of surgery with clinically different analgesic levels. In addition, the ability 
of SSI to detect nociceptive reflexes was compared with conventional clinical 
indicators of surgical stress (III). 
 
4. To evaluate the feasibility and the optimal time window for the use of 
quantitative EEG-derived monitoring indices to separate patients with good and 
poor neurological outcome after cardiac arrest. Wavelet subband entropy 
(WSE), burst suppression ratio (BSR), State Entropy (SE), and Response 
Entropy (RE) were evaluated against visual EEG signal analysis, Transcranial 
Doppler ultrasound, and biomarkers of neuronal apoptosis (IV). 
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4. Patients and methods  
 
 
Patients  
 
 
The original studies were conducted in Jorvi Hospital of Helsinki University Central 
Hospital (I), Meilahti Hospital of Helsinki University Central Hospital (II, IV), and the 
Surgical Hospital of Helsinki University Hospital (II, III) between April 1998 and 
February 2007. The local Ethics Committee of Helsinki University Hospital approved 
all study protocols. In Studies I, III, and IV, patients or their next of kin gave their 
written consent for participation after receiving written and personal information. In 
Study II, the Ethics Committee of Helsinki University Hospital did not consider consent 
by next of kin to be necessary.  
 
The total number of patients was 3913. In Study I 2360 patients were of ASA physical 
status 1, 1152 of ASA 2, 313 of ASA 3, and 16 of ASA 4. In Study II, all patients were 
brain-dead organ donors. In Study III, patients were of ASA 1-2, and in Study IV, 
patients were comatose after resuscitation from cardiac arrest.  Designs and 
demographics of the original studies are shown in Table 1.  In Study II, three cases were 
discarded due to missing data (collected original EEG data were insufficient). In Study 
III, two patients were excluded from the final analyses because of unsuccessful plexus 
blocks, and two because of lacking data (collected plethysmographic wave data were 
insufficient). In Study IV, 82 h of low-quality EEG recordings were rejected (4.7% of 
all recordings) from the analyses after visual analysis by an expert.  
 
Table 1. Study designs and patient demographics. N=number of patients, BMI=body 
mass index. Demographic data are median (range).  
 
      
Study I  II III IV 
      
Design prospective prospective prospective prospective  
 open open randomized open 
 cross-sectional observational single-blind observational 
      
      
N 3841 16 26 30 
      
Age (years) 38 (15-91) 56 (16-67) 51 (25-67) 58 (24-77) 
     
Height (cm) 166 (147-202) 173 (162-183) 173 (157-188) 175 (158-190) 
      
Weight (kg) 66 (38-146) 78 (52-110) 82 (59-114) 80 (55-140) 
      
BMI (kg/m2) 24 (14-48) 26 (20-33) 26 (20-33) 25 (19-39) 
      
Male/Female 891/2950 8/8 16/10 24/6 
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Designs and protocols of the original studies 
 
 
Study I.  The incidence of intraoperative awareness and explicit recall in outpatient 
anesthesia was studied with a standardized interview. All outpatients 15 years or older 
undergoing surgery with general anesthesia during the study period were included. 
Inpatients (patients who came through a surgical ward and stayed at the hospital 
overnight) served as controls. Patients who did not speak Finnish or Swedish or who 
were unable to respond or refused to be interviewed were excluded from the study. The 
attending nurse performed the first interview in the recovery room. The interview was 
structured and based on the questions originally described by Brice et al. (Brice et al. 
1970). Those patients who had recollections were reinterviewed during the same or 
following day. To evaluate whether patients with recollection had prolonged after-
effects (sleep disturbances, anxiety, depression, preoccupation of death), they were 
reinterviewed by phone 12-24 months after the operation. Awareness and recall were 
graded into two types: type 1 as doubtful; patients had unclear memories or dreams that 
might have been related to intraoperative events, and type 2 as certain; patients had 
clear, explicit recall about intraoperative events. Patients with possible residual 
relaxation were graded as type 2. Patients were also questioned about dreaming during 
anesthesia. Dreams were described as neutral, pleasant, or nightmares. The anesthesia 
staff was aware of the study, but no specific instructions were given to them to 
standardize their anesthesia methods.  
 
Study II. The hypothesis that Entropy would be more accurate than BIS in 
differentiating true EEG from EMG activity was tested in brain-dead organ donors. In 
addition, the sources of artifacts affecting EEG signal were evaluated. According to 
Finnish law, the diagnosis of brain death is based on clinical examination showing 
absence of both cranial nerve reflexes and spontaneous breathing. The diagnosis of 
brain death had been completed before the study began, independently of the 
researchers.  Computed tomography of the brain was performed on all patients and 
cerebral angiography on six patients before brain death was diagnosed. The cause of 
brain death was intracerebral and/or subarachnoidal hemorrhage in ten, subdural 
hematoma in three, and cerebral ischemia after hemorrhage in three cases. The mean 
interval between the clinical diagnosis of brain death and the beginning of the organ 
harvest operation was 420 ± 167 min. 
 
Study III. The ability of the Surgical Stress Index (SSI, later Surgical Pleth Index, SPI) 
to differentiate patients undergoing shoulder surgery with two clinically different 
analgesic levels was tested. The hypothesis was that during surgery SSI values would be 
lower in patients who had received an interscalene plexus block preoperatively than in 
patients who did not receive such a block. Patients were randomized (by computer-
generated random numbers sealed in envelopes) either to the plexus group (general 
anesthesia + plexus block) or to the control group (general anesthesia only). In the 
plexus group, a neurostimulator guided interscalene plexus block with mepivacaine (35-
40 ml 2% mepivacaine with 5 μg/ml epinephrine) and/or bupivacaine (15-20 ml 2% 
mepivacaine with 5 μg/ml epinephrine and 15-20 ml bupivacaine with 5 μg/ml 
epinephrine) was applied preoperatively. The first four patients received a plexus block 
with mepivacaine only. To prolong analgesia, the remaining patients were locally 
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anesthetized with a mixture of mepivacaine and bupivacaine. The block was tested (cold 
sensation, ability to adduct the shoulder and flex the forearm and hand against gravity) 
before the induction of general anesthesia, and considered sufficient if it covered 
dermatomes C3-C6 and T2. General anesthesia was induced with propofol (2 mg/kg), 
alfentanil (15 μg/kg), and rocuronium (0.4 mg/kg), and maintained with desflurane with 
50% oxygen in air. The targeted level of hypnosis was SE 50, which was achieved by 
adjusting the concentration of desflurane. Patients were intubated and mechanically 
normoventilated (EtCO2 5.0). Noninvasively measured mean blood pressure above 65 
mmHg was maintained. Increase in HR (>30 beats/min) or in blood pressure (>30 
mmHg), movement, coughing, or RE-SE difference > 5 during a 20-s period were 
considered signs of nociception and led to a bolus dose of alfentanil (0.25 mg 
intravenously). 
 
Study IV. The hypothesis that EEG-derived indices (BSR, SE, RE, WSE) would predict 
neurological outcome was tested. The time window in which these variables could 
differentiate patients with good neurological outcome from those with poor outcome, 
was also evaluated. Thirty consecutive comatose adult patients (≥ 18 years) with GCS 
of eight or below resuscitated from a witnessed ventricular fibrillation within an interval 
of < 35 min from collapse to ROSC and admitted to ICU for mild therapeutic 
hypothermia treatment were included. Patients with terminal illness, psychoactive or 
anticonvulsive medication, history of neurologic disease, or alcohol or drug abuse were 
excluded. Hypothermia of 33°C was induced immediately after arrival to ICU with an 
intravascular cooling device (CoolGard 3000, Alcius, Irvine, CA, USA). After 24 h of 
hypothermia treatment, patients were slowly (0.5°C/hour) rewarmed to normothermia. 
Pancuronium was used for muscle relaxation and to prevent shivering. Patients were 
treated according to departmental guidelines; they were kept in a 30° semirecumbent 
position and normoventilated, mean arterial blood pressure was kept above 65 mmHg, 
and blood glucose level was maintained between 4.4 and 8.0 mmol/l. Continuous 4-
channel EEG monitoring began on arrival to the ICU, and the first blood samples were 
taken. Patients regaining consciousness were extubated as soon as possible. Patients 
who remained unconscious were treated in the ICU for at least 3 days after cardiac 
arrest. Conventional multichannel EEG, CT, or SEP recording was performed if needed.  
 
 
Methods 
 
 
Interview to screen awareness 
 
 
In Study I, all patients were structurally interviewed during their stay in the recovery 
room by the attending nurse. The questions were those originally described by Brice et 
al. (1970): 1. What was the last thing you remember before going to sleep for your 
operation? 2. What is the first thing you remember on waking after your operation? 3. 
Do you remember anything in between? 4. Did you have any dreams? 5. What was the 
most unpleasant thing you remember from your operation and anesthesia? Additional 
questions asked of patients who reported awareness were as follows: 1. What did you 
notice: sounds, tactile sensations, visual perception, pain, or paralysis? 2. Did you feel 
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something in your mouth or throat? 3. What went through your mind? 4. Did you 
believe you were dreaming? 5. How long did it last? 6. Did you try to alert anyone? 7. 
How was your preoperative mental state? 8. Have there been any consequences of 
awareness? 9. Did you inform hospital staff? 10. Have you changed your opinion about 
anesthesia? 
 
Any patient suspected of having experienced awareness was reinterviewed on the 
operation day or the next day by the author. Patients with awareness were also 
reinterviewed by phone 12-24 months after the operation. Patients with explicit 
recollections were graded into two types: type 1 was doubtful (unclear memories that 
might have been related to intraoperative events), and type 2 was certain (clear explicit 
recall of intraoperative events). Patients with possible residual relaxation were included 
in the type 2 group. Patients were also asked about dreaming during general anesthesia. 
If dreams were related to possible intraoperative events, these patients were classified 
into the type doubtful awareness group. 
 
 
Premedication and sedation 
 
 
Only in Study III, was premedication standardized and routinely used. One hour before 
entering the operation theatre, 5 mg of oral diazepam was given to patients. In Study I, 
most of the inpatients and some of the outpatients were premedicated with diazepam, 
but this was not standardized. In Study II, patients were brain-dead organ donors, and 
hence, no premedication was used. In Study IV, patients were resuscitated from cardiac 
arrest and were comatose when entering ICU. During the hypothermia treatment they 
were medicated with continuous infusions of midazolam (0.125 mg/kg/h) and fentanyl 
(2 μg/kg/h), until their body temperature reached 36°C during the rewarming period.  In 
Study I, the total dose of inhaled anesthetics was calculated as follows: the inspired 
concentration was multiplied by the time the concentration was used. Concentration and 
time totals were added to form a grand total. The result was then divided by the total 
duration of anesthesia (Ranta et al. 1998). To estimate the MAC values, the total dose 
of sevoflurane was divided by 2.05 and the total dose of isoflurane by 1.15 (Koblin 
2000). 
 
 
Monitoring 
 
 
Electrocardiography (ECG), SpO2, and inspiratory and expiratory concentrations of 
oxygen and carbon dioxide were measured (Studies I-IV). Expiratory concentrations of 
isoflurane (Study I), sevoflurane (Study I), and desflurane (Study III) were measured. 
Blood pressure was monitored noninvasively every 5 min in Studies I and III. In Studies 
II and IV, arterial blood pressure was measured. Data were recorded with the S/5 
Collect 4.0 program (GE Healthcare Finland Oy) in the Studies II-IV, and manually in 
Study I. 
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EEG, BIS, and Entropy monitoring and data collection 
 
 
In all studies, skin was prepared with alcohol before electrodes were placed on the 
patient’s forehead according to manufacturers’ recommendations (Studies II and III). In 
Study II, BIS and Entropy sensors were placed in the immediate vicinity of each other 
(Entropy sensor below BIS sensor). In Study IV, electrodes were applied below the 
hairline, as shown in Figure 1. In Study IV, EEG was recorded from channels Fp1-At1, 
Fp2-At2, At1-A1, and At2-A2, and an Entropy sensor was positioned 
interhemispherically above the Fp1 and Fp2 electrodes. 
 
BIS was collected with a BIS module (version 4.0, Aspect Medical Systems, Norwood, 
MA, USA) of S/5 Compact Monitor (GE Healthcare Finland, Helsinki, Finland), and 
BIS-XP Sensor Quatro electrodes were used (Aspect Medical Systems, Norwood, MA, 
USA) in Study II. Entropy was collected with an Entropy module (GE Healthcare 
Finland, Helsinki, Finland) of S/5 Compact Monitor (GE Healthcare Finland, Helsinki, 
Finland), and Entropy Sensor electrodes were used (GE Healthcare Finland, Helsinki, 
Finland) in Studies II and III. Zipprep electrodes (Aspect Medical Systems, Norwood, 
MA, USA) were used in Study IV. The EEG sampling frequency for BIS calculation 
(Study II) was 256 Hz, and for Entropy (Studies II and III) 400 Hz. In Study IV, EEG 
was recorded with a sampling frequency of 500 Hz. Impedance values below 7.5 Ω (for 
Entropy) and 10 Ω (for BIS) were considered acceptable according to the 
manufacturers’ recommendations.  
 
 
 
Figure 1.  Placement of EEG electrodes used in Study IV. In addition, an Entropy 
sensor was located above the Fp1 and Fp2 electrodes. At1/At2 = electrode placement 
on both temporal bones laterally to the eyes. The picture is modified from Bridgers SL, 
Ebersole JS. EEG outside the hairline: Detection of epileptiform abnormalities. 
Neurology 1988; 38:146-149 and reproduced with permission from Neurology. 
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In Studies II and IV, the EEG data were converted to EDF format, which is readable 
with the Nervus EEG 3.4 viewer (Taugagreining, Reykjavik, Iceland). A senior clinical 
neurophysiologist retrospectively analyzed this converted original EEG signal offline. 
In Study II, nonprocessed EEG activity was analyzed to evaluate artifacts and possible 
residual EEG activity in brain-dead organ donors. In Study IV, the neurophysiologist 
was blinded to the clinical outcome, other electrophysiological tests, results of 
laboratory measurements, and radiological findings. Continuity, suppression, burst 
suppression, epileptiform discharges, spindles, and status epilepticus were evaluated 
from EEG (Study IV). Periods of low-quality EEG recordings were manually removed 
from the final analysis (Studies II and IV). 
 
WSE was calculated offline with Matlab (version 7.5, Mathworks, Natick, MA, USA) 
and Matlab Wavelet Toolbox (version 2.2) (Study IV). WSE was calculated with 
mother wavelet Daubenchies 3 from a scale corresponding to an EEG frequency range 
between 16 and 32 Hz. 
 
 
Surgical Stress Index (Surgical Pleth Index) 
 
 
In Study III, Surgical Stress Index (SSI, later Surgical Pleth Index, SPI) was calculated 
offline from the formula SSI = 100- (0.7 x PPGAnorm + 0.3 x HBInorm). During the 
study SSI was still under development and was therefore calculated offline. SSI was 
calculated at the following phases during general anesthesia: before incision, after 
incision, and during the rest of the operation. ”Before incision” referred to the mean SSI 
during a 10-min period immediately before incision. ”After incision” referred to mean 
SSI during the first 2-min period after the incision. “Rest of the operation” referred to 
the mean SSI during the period from 2 min after incision to extubation.  
 
The reactivity of SSI was tested before surgery with standard tetanic stimuli 5 min after 
intubation. A 30-s tetanic stimulus (80mA, 100 Hz, Innervator 252®, Fischer & Paykel, 
Auckland, New Zealand) was given above the nervus ulnaris on the wrist on the side of 
the shoulder surgery and the possible plexus block. The measurements of PPGA and 
HBI were performed on the contralateral hand (the hand not operated on).  
 
 
Trancranial Doppler Ultrasonography  
 
 
The Pulsatile Index of Transcranial Doppler Ultrasonography (TCD, Pioneer TC 4040, 
Nicolet-EME, Überlingen, Germany) was measured for each patient in Study IV. The 
middle cerebral artery was insonated at a depth of 49-55 mm. The measurement was 
taken when patients were normothermic after hypothermia treatment, but within 48 h 
after cardiac arrest. The same investigator performed all the measurements.  
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Laboratory measurements 
 
 
NSE, S-100B, creatine kinase MB, Troponin T, hemoglobin, glucose, lactate, and pH 
were measured for all patients in Study IV. Blood was sampled from an arterial catheter. 
Blood tests were sampled at the same time when EEG monitoring started on arrival to 
ICU (NSE, S-100B), 24 h after cardiac arrest (NSE), upon rewarming to 35.5°C (NSE, 
S-100B), 48 h after cardiac arrest (NSE), and when EEG monitoring ended (NSE, S-
100B). Markers of myocardial damage (creatine kinase MB and troponin T) were 
evaluated according to the ICU´s protocol daily, and arterial blood gas analysis 
(including hemoglobin, natrium, potassium, calcium, glucose, lactate, pH) was done at 
least every 4 h. The reference range for NSE was 0.05-16 μg/l, and for S-100B 0.005-
0.11μg/l (Elecsys, Roche, Basel, Switzerland). Additional NSE values were measured at 
24 and 48 h after cardiac arrest as per the ICU´s protocol. S-100B values do not belong 
to these routinely measured values and were measured only on arrival to ICU, upon 
rewarming and when EEG monitoring ended. 
 
 
Functional outcome 
 
 
In Study IV, neurologic status was examined daily during the ICU stay and also at 
discharge from the hospital. A neurologist evaluated patients six months after cardiac 
arrest, and assessed neurologic outcome with the Glasgow-Pittsburgh Cerebral 
Performance Categories (CPC).  CPC classifies outcome into five categories:  
CPC of 1 refers to normal cerebral function, 2 to moderate cerebral disability, 3 to 
severe neurologic disability, 4 to comatose or vegetative state, and 5 to death (Cummins 
et al. 1991). The overall neurologic outcome was defined as “good” if the best-achieved 
CPC score was 1 or 2 at any point within the six-month follow-up period after cardiac 
arrest. CPC scores of 3-5 indicate “poor” neurologic outcome.  
 
 
Statistical analysis 
 
 
In Study I, Chi-squared test with Yates continuity correction was used to compare 
frequencies of awareness, and Students t-test was applied for independent samples. 
Power analysis was performed to estimate the number of patients needed to be 
interviewed. The incidence of awareness in the group of inpatients was expected to be 
0.7% (based on a previous study by the same group of researchers (Ranta et al. 1998)), 
and twice as high (i.e. 1.4%) in the group of outpatients. For a significance level of 5% 
and power of 90%, 1500 patients per group were required.  
 
In Study II, recorded BIS and Entropy data were not normally distributed and were 
expressed as median and range. The demographic data were reported as mean ± 
standard deviation (SD). Wilcoxon´s test was used to compare paired samples of SE, 
RE, and BIS.  
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In Study III, the differences between plexus and control groups were evaluated with 
two-tailed Mann-Whitney tests for numeric variables and two-tailed Fisher’s exact tests 
for categorical differences. SPSS (SPSS Inc, Chicago, IL, USA) was used for all 
calculations. The consecutive measurements within one subject are correlated; 
therefore, a single mean value was calculated for the specified period. Statistical 
comparisons were performed by using these single values for different subjects. 
Significant differences were reported without correction for multiple comparisons. Pk 
statistics was used to evaluate how consistently SSI, HR, systolic blood pressure, and 
RE-SE difference could separate the low-stress situation from the high-stress situation. 
Pk was calculated with Matlab (MathWorks Inc., Natick, MA, USA). The jackknife 
method of Matlab was used to compute the standard error of the estimate (Study III).  
 
In Study III, the SSI values before patient responses requiring an alfentanil-bolus were 
compared with values during the period of no clinical nociceptive responses. The 
response SSI value of a patient was calculated as the mean of the peak SSI values that 
preceded each response that led to alfentanil administration. A one-min time window 
was used to calculate the response SSI value. If repeated alfentanil boluses were needed 
without a 5-min period between them, the latter period was not included to the 
calculation. The no-response SSI value was calculated as the mean of the peak SSI 
values from one minute in the middle of a period of no responses, and no alfentanil 
administration within 11 min (i.e. 5 min before and 5 min after the included one-minute 
period when there were no responses and no alfentanil doses were given). The response 
and nonresponse SSI values were calculated separately for plexus and control groups 
and compared between groups with the unpaired Mann-Whitney test. 
 
Power analysis was performed to estimate the required sample size also in Study III. 
Clinically significant reduction in the mean required dose of alfentanil (after the 
induction dose) was estimated to be 25%. Based on the Hospital’s clinical database, a 
minimum of 2 mg alfentanil per surgery was estimated to be the mean consumption 
during acromioplasty without preoperative plexus block but with N2O used during 
general anesthesia. To provide 80% power to detect a 25% change (two-sided) in 
alfentanil need with an alpha of 0.05, 24 patients per group were needed. N2O is 
routinely used in the study hospital, and it has an antinociceptive effect. N2O was not 
included in the study protocol in order to minimize its confounding analgesic effects in 
the control group. Hence, the power calculation was only an approximation, as patient 
data from shoulder surgery under general anesthesia without N2O did not exist. The 
results were analyzed after 30 patients, and significant differences in alfentanil 
consumption and SSI values were found. Thus, the sample size was considered 
adequate, and patient recruitment was stopped.  
 
In Study IV, patients were divided into good and poor neurologic outcome groups based 
on the CPC evaluation. All data have a non-Gaussian distribution and were given as 
medians and ranges. Mann-Whitney U-test was used to evaluate the difference between 
the medians of good and poor outcome groups for scalar parameters. Chi-squared test 
was used to test the associations between nominal scale parameters and outcome or 
EEG groups. SPSS (SPSS Inc., Chicago, IL, USA) was used for statistical analyses. 
Preliminary prediction analysis was carried out with a General Diagnostic Optimizer 
program, which uses a stepwise heuristic Bayesian process. 
A p-value of 0.05 or below was considered statistically significant (Studies I-IV). 
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5. Results 
 
 
Incidence of awareness and recall in outpatient anesthesia (Aim 1) 
 
 
In Study I, 1500 outpatients and 2343 inpatients were interviewed. During the study 
period 89% of the outpatients and 67% of the inpatients operated on under general 
anesthesia were interviewed.  
 
One of the outpatients reported a short-lasting, but clear episode of awareness. Four 
other outpatients reported doubtful awareness. Long-lasting episodes were not detected 
among the outpatients. Three inpatients described clear episodes of awareness and three 
additional patients described doubtful awareness. The incidence of clear awareness was 
0.07% among outpatients and 0.13% among inpatients when they were interviewed in 
the recovery room. No statistical difference was present in the incidence of awareness 
between the groups. 
 
Patients with clear or doubtful awareness were interviewed a second time 12-24 months 
after the surgery. Five outpatients and three inpatients with awareness had the same 
recollections as in the first interview. Three inpatients (who had recollections in the first 
interview) did not have persisting recollections in the second interview. 
 
All of the patients with awareness were females (in both study group), but the difference 
in sex distribution was not significant (p=0.08). Nor was there a difference in ASA 
physical status, body mass index (BMI), or age between the patients with and without 
awareness. Only one patient experienced pain. Altogether 22% of outpatients and 14% 
of inpatients reported neutral or pleasant dreams. Dreaming was more common in 
women. Of the patients with awareness, one outpatient reported nightmares and sleep 
disturbances, and one inpatient depression as after-effects from awareness. 
 
Benzodiazepine premedication was administered to 88% of inpatients and 15% of 
outpatients. No difference in the incidence of awareness was found between patients 
with and without premedication. The proportions receiving NMBAs were 97% of 
inpatients and 19% of outpatients. No difference emerged in the incidence of awareness 
between patients who had received muscle relaxants and those who had not. Outpatients 
with awareness received less sevoflurane than outpatients without this complication 
(p<0.05) (Study I). 
 
 
BIS and Entropy monitoring in brain-dead organ donors (Aim 2) 
 
 
In Study II, Entropy and BIS data from 16 brain-dead organ donors were recorded 
during organ harvest surgery.  SE differed from zero in 28% (range 3-99%), RE in 29% 
(4-99%), and BIS in 68% (16-100%) of the recorded time. SE, RE, and BIS values over 
40 were recorded in 1%, 1%, and 4% of the total recorded time, respectively. The 
 54
median SE during the organ harvest operation was 0.0 (range 0-91), the median RE was 
0.0 (0-100), and the median BIS was 3.0 (0-98). SE, RE, and BIS were all significantly 
different from 0 (p<0.0001), and RE > SE, BIS > SE, and BIS > RE  (p<0.0001 in all 
cases). The median BSR recorded with the Entropy Module was 100.0 (range 0-100).  
 
Offline analysis of the time-domain EEG revealed some persistent unphysiologically 
distributed, nonreactive, rhythmic θ-activity with an amplitude between 10 and 40 μV 
during the initial or entire monitoring in four of 16 cases (Figure 2). After excluding 
cases with residual EEG, the median SE was 0.0 (range 0-90), median RE was 0.0 (0-
98), and median BIS was 2.0 (0-96). The indices differed from zero as follows: SE 17%, 
RE 18%, and BIS 62% of the recorded time (Figure 3). 
 
 
 
 
Figure 2.  Persistent, nonreactive, rhythmic, low-amplitude EEG activity in clinically 
brain-dead organ donor. 
 
 
Figure 3. Proportions of operating time when SE, RE, and BIS were zero, 1-10, 11-40, 
and 41-100, after excluding recordings containing residual EEG.  
 
 
Sources of EEG signal artifacts (Aim 2) 
 
 
Electrocauterization, handling of the patient, ballistocardiography (caused by small 
rhythmic movements of the head induced by cardiac contraction and ejection of blood 
through the vessels), EMG, 50-Hz artifact, ECG, and external warmer all caused 
artifacts to the EEG signal and falsely increased the values of EEG-based indices (Study 
II). Figure 4 demonstrates different artifacts and the related original EEG recordings. 
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Figure 4. Different artifacts in the EEG recordings. (A) ECG with 50-Hz interference. 
(B) Tachycardic ECG signal. (C) Rhythmic slow oscillation due to 
ballistocardiography. (D) EMG artifact eliminated by neuromuscular blockade (arrow). 
Note that ECG artifact persists after administration of NMBA. (E) Movement artifacts. 
(F) External warmer. (G) Electrocauterization, large artifact blocks the amplifier for 2 
s. 
 
 
The highest BIS and Entropy values were recorded without muscle relaxation. Initially 
high BIS indices decreased after administration of NMBAs. The median decline in BIS 
index after administration of NMBA was 1.0 (0-61) (p<0.05). Entropy indices did not 
decrease as markedly; the median ΔSE was 0.0 (0-1), and the median ΔRE was 0.0 (0-
2). SE and RE decreases were not statistically significant (Figure 5). 
 
Extended use of electrocauterization or handling of the donor increased indices in 81% 
of organ donors. In 44% of recordings, the source of recorded electrical potential was a 
ballistocardiography, in 38% of cases EMG, and in 25% of cases a 50-Hz artifact. In 
19% of the recordings, an ECG artifact was noted. The ECG artifact was usually related 
to tachycardia (HR over 100 beats/minute), and well visible in the time-domain EEG.  
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Figure 5. Typical course of BIS and SE trend recordings during organ harvest.  1 = 
administration of the neuromuscular blocking agent, 2 = sternotomy, 3 = organ 
perfusion with preservation fluid. 
 
 
SSI (SPI) levels during shoulder surgery with clinically different analgesic levels 
(Aim 3) 
 
 
SSI (SPI) in 26 patients undergoing shoulder surgery under general anesthesia with or 
without interscalene plexus block (plexus group and control group, respectively) was 
recorded continuously from the unoperated side. Preoperatively, after tetanic stimulus, 
the increase in SSI was 26 ± 21 in the plexus group and 23 ± 17 in the control group. 
The difference between the groups was not significant. However, in four patients, 
plexus block covered also the ulnar side of the hand. Among these four patients, SSI did 
not increase (ΔSSI 0.5 ± 3) during tetanic stimulation, indicating efficacy of the plexus 
block (Figure 6). 
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Figure 6. Change of SSI (ΔSSI) in response to tetanic stimulus at the ulnar side of the 
wrist (* p<0.05 compared with patients with no ulnar block in the plexus group and ** 
p<0.01 compared with control group patients).  
 
 
 
 
Before the skin incision, SSI values were similar in the plexus and control groups (38 ± 
11 vs. 39 ± 10). During the first two minutes after skin incision SSI showed lower 
values in the plexus group than in the control group (38 ± 13 vs. 58 ± 13, p<0.005). The 
mean SSI during the rest of the anesthesia did not differ between plexus and control 
groups (46 ± 9 vs. 48 ± 10). Figure 7 demonstrates typical SSI and Entropy trends 
during anesthesia and surgery in patients with and without plexus block (Figure 7).  
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Figure 7. SSI and Entropy trends (SE, solid line and RE, dotted line) a) in a patient 
without a plexus block and b) with an effective plexus block covering also the ulnar 
nerve distribution. 
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Pk value ± SD was used to compare the ability of SSI and traditional hemodynamic 
parameters to detect the higher stress level (=increased parameter values after the 
nociceptive stimulus). Pk values before vs. after skin incision in the control group: SSI 
0.88 ± 0.07, Systolic Blood pressure (BPsys) 0.65 ± 0.12, HR 0.69 ± 0.12, RE-SE 
difference (RE-SE) 0.63 ± 0.13, after skin incision in the plexus vs. control groups: SSI 
0.86 ± 0.08, BPsys 0.79 ± 0.10, HR 0.79 ± 0.10, RE-SE 0.60 ± 0.13, before vs. after 
tetanic stimulation in the control group: SSI 0.88 ± 0.09, BPsys 0.65 ± 0.14, HR 0.66 ± 
0.13, RE-SE 0.66 ± 0.14, and before vs. after tetanic stimulation in patients with plexus 
block that had not spread to the ulnar side: SSI 0.88 ± 0.10, BPsys 0.49 ± 0.16, HR 0.66 
± 0.16, RE-SE 0.69 ± 0.17. HR, BPsys and SSI values at various time-points during the 
anesthesia and surgery are given in Table 2. 
 
 
 
 
Table 2. Surgical Stress Index (SSI), heart rate (HR), and noninvasive systolic blood 
pressure (NIBP) at various time-points.  
 
A diminished need for additional alfentanil analgesia in the plexus group was detected. 
In the plexus group, alfentanil was administered 25 times, and in the control group 86 
times. In the plexus group, the reason for alfentanil administration was increased HR 
and/or BPsys four times, RE-SE > 5 over 20 s 15 times, and a combination of these 
indicators six times. In the control group, the reason for alfentanil administration was 
increased HR and/or BPsys 70 times, RE-SE > 5 over 20 s once, and a combination of 
these indicators 15 times. The mean number of alfentanil boluses given per patient after 
the induction of anesthesia was 1.8 ± 1.8 and 7.2 ± 4.2 in the plexus and control groups, 
respectively (p<0.001). The total cumulative dose of alfentanil during anesthesia 
(including induction dose) was 1.6 ± 0.5 mg and 2.7 ± 1.2 mg in the plexus and control 
groups, respectively (p=0.008). SSI and HR values, cumulative alfentanil dose, RE, SE, 
and desflurane concentrations at different time-points during general anesthesia are 
presented in Figure 8. 
 
In the plexus group, the response SSI was 47 ± 14 (n=9), and the no-response SSI value 
was 45 ± 12 (ns). In the control group, the response SSI value was 59 ± 11 (n=12), and 
the no response SSI value was 39 ± 12 (p<0.01). The response SSI value was calculated 
as the mean of the peak SSI values preceding each response leading to additional 
alfentanil administration (one-minute window). The no-response SSI value was 
Time SSI 
Plexus 
SSI 
Control 
 HR 
Plexus 
HR  
Control 
 NIBP 
plexus 
NIBP 
control 
 
Before 
intubation 
45 ± 10 48 ± 11 N.S. 67 ± 10 69 ± 12 N.S. 158 ± 
31 
138 ± 
37 
N.S. 
After intubation 53 ± 8 51 ± 10 N.S. 71 ± 10 75 ± 18 N.S. 147 ± 
27 
137 ± 
40 
N.S. 
Before incision 38 ± 11 39 ± 10 N.S. 66 ± 12 67 ± 17 N.S. 116 ± 
14 
128 ± 
23 
N.S. 
After incision 38 ± 13 58 ± 13 P=0.001 64 ± 11 78 ± 14 P=0.01 115 ± 
14 
139 ± 
25 
P= 0.01 
After 5 min 40 ± 11 44 ± 9 N.S. 64 ± 10 74 ± 18 N.S. 116 ± 
15 
150 ± 
26 
P= 
0.001 
After 10 min 43 ± 9 44 ± 17 N.S. 64 ± 11 72 ± 19 N.S. 117 ± 
14 
144 ± 
30 
P= 
0.013 
After 15 min 41 ± 9 44 ± 14 N.S. 63 ± 10 74 ± 22 N.S. 115 ± 
18 
152 ± 
22 
P= 
0.000 
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calculated as the mean of the peak SSI values from one minute in the middle of a period 
of no-responses and no additional administration of alfentanil within 11 min. For more 
details, see the statistical analysis in the Methods section.  
 
 
 
 
 
 
Figure 8. Mean ± SEM SSI and HR values, cumulative alfentanil dose, Response and 
State Entropy, and desflurane concentrations at different time-points during general 
anesthesia. Before incision= mean value during a 10-min period before incision, 
incision= mean value up to two minutes after incision, and after incision= mean value 
from two minutes after incision to extubation. Cumulative alfentanil doses are given as 
total doses given before the end of these specific time-points, respectively. Statistical 
comparisons were done between the groups. 
 
 
 
Ability and time schedule of the quantitative EEG variables (WSE, BSR, SE, and 
RE) to differentiate patients with good and poor neurological recovery (Aim 4) 
 
In Study IV, EEG monitoring was started 3-13 h after cardiac arrest. A total of 1754 h 
of EEG was recorded. After manual rejection of low-quality EEG signal and artifacts, 
667 h of EEG (22/patient) registered in the first 24 h after cardiac arrest, and 541 h (18 
h/patient) in the period between 24 and 48 h after cardiac arrest were further analyzed.   
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Twenty-one patients had a best CPC of 1 or 2 (CPC 1: 13 patients, CPC 2: 8 patients), 
four patients had a CPC of 3, and five patients had a CPC of 4 during the six-month 
follow-up period. At six months after cardiac arrest, nine patients had died, and 21 were 
alive. No patient remained in a persistent vegetative state. Five patients remained 
comatose until the treatment was withdrawn. All patients with CPC 1 or 2 (described as 
good neurological outcome) returned home. Baseline demographics and clinical 
characteristics were similar in both outcome groups (Table 3).  
 
 
 
       
  Good outcome (n=21) Poor outcome (n=9)          p 
     
Age 55 (24-74) 60 (26-77) 0.176
Sex (male/female) 16 / 5  8 / 1 0.426
BMI (kg/m2) 25 (19-35) 28 (21-39) 0.209
GCS 3 (3-8) 3 (3-5) 0.278
SOFA 24 h 8 (3-12) 9 (5-13) 0.304
ROSC (min) 16 (9-33) 22 (15-31) 0.104
CPR (yes/no) 14 / 7 6 / 3 0.500
BCLS (min) 7 (3-13) 7 (5-11) 0.406
ACLS (min) 14 (3-35) 16 (12-25) 0.263
Time to target temperature (h) 3 (1-5) 2 (0-13) 0.449
Time to normothermia (h) 32 (30-36) 31 (30-39) 0.304
LOS ICU (days) 3 (1-14) 4 (2-13) 0.244
LOS Hospital (days) 18 (5-36) 13 (5-31) 0.226
 
 
 
 
Table 3. Demographics and baseline clinical characteristics in Study IV. 
BMI = body mass index, GCS = Glasgow Coma Scale on admission, SOFA = Sequential Organ Failure 
Assessment, ROSC = return of spontaneous circulation, CPR = bystander cardiopulmonary resuscitation, 
BCLS = response interval to basic cardiac life support, ACLS = response interval to advanced cardiac 
life support, Time to target temperature since arrival to ICU, Time to normothermia since initiating 
hypothermia treatment, LOS ICU = length of stay at intensive care unit, LOS Hospital = length of stay at 
Helsinki University Hospital.  
 
 
 
When EEG monitoring started, all patients demonstrated a slow burst suppression 
pattern in EEG, which gradually subsided and a low-amplitude rhythmic activity 
appeared. There were no differences in the occurrence of continuous EEG between the 
outcome groups during hypothermia, but during normothermia, the good outcome group 
more often showed continuous EEG than the poor outcome group (p<0.001). Status 
epilepticus during normothermia was related to poor neurological outcome (p=0.001). 
Other EEG patterns were not associated with outcome. Findings in visually analyzed 
EEG during hypo-and normothermia according to outcome are presented in Table 4. 
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Table 4. EEG findings during hypo- and normothermia according to outcome. Values 
are numbers and percentages.  
 
Patients with good outcome had significantly lower BSR (shorter suppression episodes) 
during the first 48 h after cardiac arrest than patients with poor outcome. This difference 
in BSR was more pronounced during hypothermia. SE and RE were significantly higher 
in the good outcome group during the first 24 h, but not during the period between 24 
and 48 h. WSE was at borderline higher in the good outcome group during the period 
from 24 to 48 h (Table 5).   
 
 
 
Table 5. Median and range of quantitative parameters associated with good and poor 
neurological outcome during the first and second day after cardiac arrest.  
WSE = wavelet subband entropy, BSR = burst-suppression ratio, RE = Response 
Entropy, SE = State Entropy 
 
 Good outcome, n = 21 
(%) 
Poor outcome, n = 9 
(%) 
Hypothermia   
Continuous EEG 14 (67) 4 (44) 
Discharges 1 (5) 3 (33) 
Suppression/ B-S 5 (24) 1 (11) 
Status epilepticus 
Spindles 
Myoclonia 
 
Normothermia 
0 (0) 
1 (5) 
0 (0) 
0 (0) 
0 (0) 
1 (11) 
Continuous EEG 20 (95)* 3 (33)¤ * 
Discharges 1 (5) 1 (11) 
Suppression/ B-S 0 (0) 1 (11) 
Status epilepticus 0 (0)** 4 (44)** 
Spindles 0 (0) 0 (0) 
Myoclonia 0 (0) 0 (0) 
   
B-S = Burst suppression.  ¤ Theta coma 
 
. * p < 0.001, ** p = 0.001  
     
     
  Good outcome (n = 21) Poor outcome (n= 9) p 
     
0-24h       
  WSE 0.84 (0.75 - 0.85) 0.83 (0.69 - 0.85) 0.137 
  BSR (%) 18 (0 - 81) 65 (4 - 74) 0.011 
  RE 20 (3 – 51) 10 (4 - 22) 0.011 
  SE 19 (3 - 50) 9 (4 - 22) 0.008 
       
 24-48h       
  WSE 0.84 (0.80 - 0.86) 0.82 (0.65 - 0.85) 0.050 
  BSR (%) 0 (0 – 17) 2 (0 - 26) 0.045 
  RE 67 (26 - 83) 55 (29 - 78) 0.150 
  SE 58 (24 - 76) 46 (28 - 68) 0.193 
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Status epilepticus patients had lower WSE between 24 and 48 h than other patients (p= 
0.022). The evolution of WSE in status epilepticus patients is presented in Figure 9. A 
neurophysiologist defined the onset of status epilepticus in each patient as the time- 
point when discharges over 50% of the time were detected. In Figure 9, the onset of 
status epilepticus was set to 0 h, and the hourly distribution of WSE from 12 h before to 
24 h after the beginning of status epilepticus are given. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Evolution of WSE in status epilepticus patients. The beginning of status 
epilepticus is denoted by 0 h. The distribution of hourly WSE values between 12 h 
before and 24 h after onset of status epilepticus is shown. The box displays the 
distribution from the 25th to 75th percentile. The horizontal line within the box 
represents the median value. The whiskers cover the distribution up to 1.5 times the box 
length from the edges of the boxes. The boxes depict the distribution of hourly average 
values within the group.  
 
 
Sensitivity, specificity, positive prediction value (PPV), and negative prediction value  
(NPV) for the prediction of poor neurological outcome after cardiac arrest were 
calculated. In Table 6, thresholds of WSE, BSR, SE, RE, NSE, and S-100B are adjusted 
to maximize the number of correctly predicted outcomes. In Table 7, the thresholds of 
these variables are adjusted for 100% specificity. 
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Variable  Threshold Sens Spec PPV NPV 
 
WSE 24h   0.84 0.89 0.52 0.44 0.92 
WSE 48h   0.83 0.67 0.71 0.50 0.83 
BSR 24h   21 0.89 0.62 0.50 0.93 
BSR 48h   0 0.89 0.57 0.47 0.92 
RE 24h   13 0.78 0.81 0.64 0.89 
RE 48h   64 0.89 0.62 0.50 0.93 
SE 24h   12 0.78 0.81 0.64 0.89 
SE 48h   56 0.89 0.57 0.47 0.92 
NSE 0h   19 0.44 0.48 0.27 0.67 
NSE 24h   21 0.56 0.62 0.38 0.76 
NSE 35.5°C   20 0.78 0.71 0.54 0.88 
NSE 48h   20 0.78 0.80 0.63 0.89 
NSE end   16 0.63 0.78 0.55 0.83 
S100B 0h   0.36 0.78 0.81 0.64 0.89 
S100B 35.5°C   0.10 0.89 0.76 0.62 0.94 
S100B end   0.09 0.88 0.44 0.40 0.89 
 
Table 6. Sensitivity, specificity, positive prediction value, and negative prediction value 
for the prediction of poor neurological outcome.  
Sens= sensitivity, Spec= specificity, PPV= positive prediction value, NPV= negative 
prediction value, WSE= wavelet subband entropy, BSR= burst suppression ratio, RE= 
Response Entropy, SE= State Entropy, NSE= neuron-specific enolase, S100B= protein 
100B 
 
Variable  Threshold Sens Spec PPV NPV 
 
WSE 24h   0.74 0.22 1.00 1.00 0.75 
WSE 48h   0.77 0.33 1.00 1.00 0.78 
BSR 24h   82 0.00 1.00 - 0.70 
BSR 48h   22 0.11 1.00 1.00 0.72 
RE 24h   2 0.00 1.00 - 0.70 
RE 48h   25 0.00 1.00 - 0.70 
SE 24h   2 0.00 1.00 - 0.70 
SE 48h   23 0.00 1.00 - 0.70 
NSE 0h   33 0.00 1.00 - 0.70 
NSE 24h   52 0.11 1.00 1.00 0.72 
NSE 35.5°C   40 0.11 1.00 1.00 0.72 
NSE 48h   59 0.11 1.00 1.00 0.72 
NSE end   66 0.13 1.00 1.00 0.73 
S100B 0h   0.82 0.33 1.00 1.00 0.78 
S100B 35.5°C   0.20 0.33 1.00 1.00 0.78 
S100B end   1.00 0.00 1.00 - 0.70 
 
Table 7. Sensitivities, specificities, positive prediction values and negative prediction 
values for the prediction of poor outcome. The thresholds of the variables are adjusted 
for 100% specificity. 
Sens= sensitivity, Spec= specificity, PPV= positive prediction value, NPV= negative 
prediction value, WSE= wavelet subband entropy, BSR= burst suppression ratio, RE= 
Response Entropy, SE= State Entropy, NSE= neuron-specific enolase, S100B= protein 
100B 
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The combination of WSE (from the first 24 h after cardiac arrest) and S-100B (after 
normothermia was reached) predicted correctly the outcomes of 26 of 30 patients. The 
Bayesian approach for this combination resulted in sensitivity of 89%, specificity of 
86%, positive prediction value of 73%, and negative prediction value of 95%. Other 
combinations were also tested. Among the combinations of two variables (S-100B at 
35.5°C, WSE 24 h after cardiac arrest, BSR 24 h after cardiac arrest, and NSE 24 h after 
cardiac arrest), the combination of WSE and S-100B predicted outcome most 
accurately. 
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6. Discussion 
 
 
Methodology 
 
 
Design 
 
 
In certain patient groups, such as those undergoing anesthesia for cardiac, emergency 
trauma, or obstetric surgery, an increased risk for intraoperative awareness has been 
reported (Ghoneim and Block 1992, Ghoneim et al. 2009). In Jorvi Hospital, where 
Study I was conducted, no cardiac surgery was performed. Therefore, any conclusions 
from the results should be considered by taking into account the patients included. 
Patients unable to respond because of their condition (too sick) were also excluded and 
this may have had an influence on the results. Furthermore, in Study I patients were 
interviewed only once during their stay in hospital. Several studies have subsequently 
shown that repeated interviews during the first postoperative weeks may be needed to 
improve detection of cases with awareness and recall (Macleod and Maycock 1992, 
Sandin et al. 2000, Ghoneim et al. 2009).  
 
In Study I, cases of awareness were classified as doubtful or certain. Incidence 
percentages are based on the patients with clear explicit recall of intraoperative events. 
In clear cases of intraoperative recollections, there are no problems in deciding whether 
or not the patient has been aware during the anesthesia. The decision is much more 
difficult with a patient with vague memories or dreams possibly related to intraoperative 
events. Because of the difficulty in definition of awareness, also patients with vague 
memories or dreams were reported in the results.  
 
A relatively small and homogeneous population of ASA 1-2 patients participated in the 
Study III. Elderly or overweight patients and patients with a known history of untreated 
hypertension, medication affecting the central nervous system, history of neurological 
or connective tissue diseases, diabetes, or a history of alcohol or drug abuse were not 
included. Studies with larger populations, including also the above-mentioned patient 
groups, are needed in the future to test the feasibility of SSI.  
 
 
 
Analgesics, local anesthetics, epinephrine 
 
 
According to the protocol in the Study III, the induction dose of alfentanil was 15 
μg/kg, which followed the clinical practice of the participating hospital (Surgical 
Hospital). The rescue dose of alfentanil was set at 0.25 mg. Outside the study, the 
commonly used bolus dose of alfentanil would be 0.5-1.0 mg for high BP, HR, sweating 
or movements. A low rescue dose was chosen to enable differentiation between ongoing 
nociception and unspecific reasons for these autonomic reactions. Uncovered 
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nociception needed several 0.25-mg doses of alfentanil, and it was not confused with 
spontaneous variation in baseline HR level. 
 
The first four patients in Study III received only mepivacaine for their brachial plexus 
block.  For the purpose of prolonged postoperative analgesia the remaining patients 
received a mixture of mepivacaine and bupivacaine. The quality of all blocks was tested 
before the induction of general anesthesia, and the duration between anesthesia 
induction and start of surgery was short. Therefore, it may be relatively safe to conclude 
that in the patients with recorded successful block, the analgesic effect 
of mepivacaine and of the mixture of mepivacaine and bupivacaine covered the total 
duration of surgery, and the local anesthetic probably did not cause any bias in the 
results. 
 
Interscalene plexus block was performed with 5 μg/ml of epinephrine. Epinephrine was 
used in both groups to minimize bleeding. Local anesthetics or epinephrine may have 
had an influence on peripheral circulation and PPGA and HBI values through 
absorption into the circulation and systemic distribution, inducing changes in skin 
microcirculation. However, there was a similar increase in SSI after tetanic stimulus in 
the plexus group patients in whom the plexus block did not cover the ulnar side of the 
wrist, but who had received a small dose of epinephrine with the local anesthetic 
solution, and in those patients with no plexus block at all. This implies that the increase 
was because of nociception, rather than because of the epinephrine of the local 
anesthetic solution. Likewise, the SSI level prior to skin incision was similar between 
groups. The effect of the small amount of epinephrine seemed not to be a major 
confounding factor in Study III. However, in future studies, the blood concentration of 
epinephrine should be measured. 
 
 
EEG 
 
 
BIS (Study II) and Entropy (Studies II-IV) sensors were placed on the patient’s 
forehead according to manufacturers´ instructions. In Study II, both BIS and Entropy 
sensors were used, and they were placed next to each other on the patient’s forehead. 
Using Entropy or BIS with an S/5 monitor, it is possible to choose the original time-
domain EEG signal on the monitor display, not only the index trends. Derivations used 
in Entropy and BIS monitoring are not compatible with the classical 10-20 electrode 
system, only being compatible with the one recommended by the manufacturers. The 
closest one resembling a 10-20 system derivation would be Fpz – F7 (or Fpz - F8). In 
Study IV, EEG electrodes were placed below the hairline to record channels Fp1-At1, 
Fp2-At2, At1-A1, and At2-A2. Because EEG was recorded with a very limited number 
of channels, it did not exclude residual EEG (Study II) or epileptiform activity (Study 
IV) that might have been recorded from 10-20 system locations. Rather high electrode 
impedances are acceptable according to the manufacturers (Entropy below 7.5 kΩ, BIS 
below 10 kΩ), which may give rise to more artifacts than in conventional EEG 
recordings (below 2 kΩ). The difference in the highest accepted electrode impedance 
may also be one of the reasons why Entropy was more resistant to artifacts during organ 
harvest (Study II). 
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Hemodynamic monitoring 
 
 
Blood pressure was measured noninvasively (NIBP) and intermittently in Study III. Had 
blood pressure been measured continuously with an arterial line, the measurement 
would have reacted faster to changes in nociception. However, intermittently measured 
blood pressure and SSI are noninvasive and monitored with sensors routinely used in 
the operation theater. Thus, comparing the performance of SSI and NIBP is for most 
anesthesiologists more relevant than comparing the performance of SSI and invasive 
BP.  
 
 
Outcome parameters 
 
 
In Study IV, neurologic outcome after cardiac arrest was assessed with the Glasgow-
Pittsburgh Cerebral Performance Categories (CPC) (Cummins et al. 1991). The overall 
neurologic outcome was defined as “good” if the best-achieved CPC score was 1 or 2 at 
any point within the six-month follow-up period after cardiac arrest. CPC scores from 3 
to 5 referred “poor” neurologic outcome. Best-achieved CPC was chosen rather than 
final CPC at six months after cardiac arrest because some patients initially recover good 
neurological function, but die later of non-neurological causes. 
 
 
Sample size and statistical analysis  
 
 
At the time when sample size of the Study I was determined, no figure for incidence of 
awareness in outpatients was available in the literature. The hypothesis was that 
outpatients would be at higher risk for awareness. This was based on the assumption 
that the pressure for fast tracking and rapid recovery would predispose outpatients to 
receive less anesthetics, leading to increased risk for awareness. Power analysis was 
used to estimate the number of patients needed to be interviewed. For this purpose, it 
was estimated that the incidence of awareness would be 0.7% in the group of inpatients, 
and 1500 patients per group would be needed to detect a significant difference if the 
incidence of awareness were two times higher in the group of outpatients. The incidence 
of 0.7% in inpatients was based on a previous study by the same group of researchers 
(Ranta et al. 1998). If Study I were repeated today, the incidence of awareness would be 
anticipated to be lower than 0.7%. However, because contrary to the primary 
hypothesis, the incidence of awareness appeared to be even smaller (although not 
significantly) in outpatients than in inpatients, it may be relatively safe to conclude that 
outpatient surgery does not predispose patients to an increased risk of awareness. 
Altogether 89% of the consecutive outpatients and 67% of the inpatients were 
interviewed. The proportion of interviewed patients and the absolute number of patients 
(n=3843) were considered large and sufficiently representative of the hospital patient 
population not to cause any major sample bias.  
Doses of anesthetics were compared between patients with awareness and those without 
it (Study I). A sample of 600 anesthetic records was considered representative to 
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describe the average doses of anesthetics. Case matching would have been another 
option for the statistical analysis. The benefit of case match would be less of data 
collection. On the other hand, there might have been a problem in finding suitable 
matches, especially as it is likely that more than one matching character would be 
needed. Thus, there would have been a danger of over-matching.  
 
Power analysis was performed to estimate the required sample size also in Study III. 
Clinically significant reduction in the mean required dose of alfentanil (after the 
induction dose) was estimated to be 25%. Based on the Hospital’s clinical database, a 
minimum of 2 mg alfentanil per surgery was estimated to be the mean consumption 
during acromioplasty without preoperative plexus block but with N2O used during 
general anesthesia. To provide 80% power to detect a 25% change (two-sided) in 
alfentanil need with an alpha of 0.05, 24 patients per group were needed. N2O is 
routinely used in the study hospital and it has an antinociceptive effect. N2O was not 
included in the study protocol to minimize its confounding analgesic effects in the 
control group. Hence, the power calculation was only an approximation, as patient data 
from shoulder surgery under general anesthesia without N2O were unavailable. The 
results were analyzed after the first 30 patients, and significant differences in alfentanil 
consumption and SSI values emerged. Thus, the sample size was considered adequate, 
and patient recruitment was stopped.  
 
In Study III, the performance evaluation was used to compare how consistently SSI, 
HR, BPsys, and RE-SE could separate the low stress situation (before incision or 
effective plexus block at the site of nociception) from the high stress situation (after 
tetanic stimulus without effective block at the site of stimulation or skin incision in 
control group). When separating two reference values, as in this study, the Pk value of 
two categories is equal to the area under the curve of a ROC plot, which is a commonly 
used measure of the performance of a parameter predicting a known difference. 
 
The limited number of patients in Study IV did not allow statistically reliable testing of 
the prediction properties of the measured indicators. Reporting a prediction model based 
on a combination of EEG-based indices and blood markers would have been clinically 
interesting. Preliminary results of the prediction powers of selected indicators are 
presented. A stepwise Bayesian classifier, which does not assume normal distribution of 
the variables, was used to examine the prediction power of a combination of EEG 
parameters and biochemical markers. The model correctly predicted the outcomes of 26 
of the 30 patients, resulting in a sensitivity of 89%, a specificity of 86%, a positive 
prediction value of 73%, and a negative prediction value of 95%. The results are, 
however, preliminary, and the model should be tested with a separate independent 
group of patients. Other combinations than WSE + S100B were also tested, but among 
the combinations of two variables (one blood marker and one EEG-derived index), 
WSE and S-100B predicted outcome more reliably than others. Following the advise of 
an outside statistician, a p-value of 0.05 (WSE, Study IV) was reported as significant; 
the exact value was under 0.050 before rounding off to three decimals.  
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Incidence of explicit awareness and recall in outpatient anesthesia (Aim 1) 
 
 
Results of Study I indicate that outpatients are not at increased risk for awareness during 
general anesthesia compared with inpatients. The results are in line with Enlund and 
Hassan (2002), who prospectively evaluated 5216 day-case or short-stay patients with a 
Brice interview and found that none of the patients interviewed indicated awareness. 
The incidence of awareness among inpatients in Study I was smaller than earlier 
incidence figures (Liu, WH et al. 1991, Ranta et al. 1998). The true incidence of 
awareness might have been underestimated because patients unable to respond due to 
their condition or those refusing to be interviewed were excluded. The incidence of 
awareness and recall might have been higher had patients with at increased risk for 
complications been included.  
 
Premedication was administered to 15% of outpatients and 88% of inpatients. No 
difference in the incidence of awareness was found with respect to premedication, 
which agrees with the suggestion of a minor role of premedication in protection from 
awareness (Sandin et al. 2000). However, the timing of premedication in relation to the 
operation was not standardized, and the duration of surgery varied considerably. 
Therefore any conclusions about the effect of premedication on the incidence of 
awareness should be drawn cautiously.  
 
Only 19% of outpatients received NMBAs, in contrast to 97% of inpatients. One 
outpatient with clear awareness, and four outpatients with doubtful awareness, all 
without muscle relaxants, emerged (Study I). No difference was seen in the incidence of 
awareness with respect to the administration of NMBAs. However, Study I was not 
designed to detect significant differences in the incidence of awareness in relation to the 
administration of NMBAs.  
 
Contrary to the primary hypothesis, dosing of anesthetics was similar during in- and 
outpatient surgery. When isoflurane and sevoflurane were converted to MAC-
equivalents, no significant difference in the dosing of inhaled anesthetics between 
outpatients and inpatients was found. Outpatients with awareness received smaller doses 
of sevoflurane during the maintenance of their general anesthesia than outpatients 
without awareness. However, the statistical difference in the dosing of anesthetics 
between the patients with and without awareness should be considered cautiously 
because of the small overall incidence of awareness. Further, no difference in the dose 
of isoflurane, the main volatile anesthetic in inpatients, was observed between patients 
with and without awareness and recall. Nevertheless, the finding with sevoflurane may 
indicate that smaller dosing of anesthetics is a major factor in predisposing patients to 
awareness (Ghoneim et al. 2009). 
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Effect of EEG artifacts on BIS and Entropy monitoring in brain-dead organ 
donors (Aim 2)  
 
 
In Study II, BIS and Entropy monitoring in brain-dead organ donors during organ 
harvest was evaluated in order to determine the robustness of these methods in artifact 
rejection. Brain death was diagnosed according to Finnish law and legislations. Clinical 
examination, apnea challenge test and CT were performed on all patients. If 
angiography was performed (in eight patients), it was done on arrival to hospital for 
diagnostics, not as a confirmatory test for the diagnosis of brain death. Multichannel 
EEG measurement as a confirmatory test was not performed. This special group of 
patients was chosen with the assumption that at least most of the biosignals measured 
from forehead should consist of signals other than EEG (i.e. artifacts).  
 
BIS and Entropy indices differed from zero in brain-dead organ donors for noticeably 
long periods during the organ harvest (SE in 28%, RE 29%, and BIS 68% of total 
recorded time). The result may indicate better detection and rejection of EEG epochs 
containing artifacts with Entropy monitoring than with BIS. Residual EEG activity was 
detected in four of 16 clinically brain-dead organ donors. CT of these patients showed 
herniation in two cases and severe brainstem injury in the other two cases. 
 
At onset of brain death, patients are usually treated in the ICU with mechanical 
ventilation and numerous other electronic devices, possibly disturbing the EEG 
recording. In Finland, the diagnosis is based on clinical examination only, but as a 
confirmatory test EEG (which must demonstrate electrocortical silence over 30 min) is 
utilized in many countries (Haupt and Rudolf 1999, Randell 2004). Several biological 
and technical artifacts are related to the use of EEG in the diagnosis of brain death, but 
they are readily recognized in the visual analysis of the time-domain signal. EEG-based 
indices have also been suggested for the use of detection of brain death onset (Vivien et 
al. 2002). SE, RE, and BIS are equal to zero when their suppression detection 
algorithms assume suppressed EEG for a sufficiently long time. Index calculation from 
the original EEG adds more potential sources of error because artifacts cannot always 
be traced. In Study II, the sources of errors increasing the indices were evaluated, and 
several situations with erroneous increase of indices were detected. Whether special 
circumstances, such as metabolic disorders or mild hypothermia, could induce false- 
zero index values were not evaluated. 
 
BIS and Entropy are recorded from a single derivation from the forehead 
(approximating Fpz – F7 or Fpz -F8) that does not represent the whole brain area. Index 
values equal to zero in the frontal region could be recorded in brain-dead patients if no 
artifacts were present in the EEG. However, this cannot guarantee that there is no EEG 
activity outside the frontal region. Therefore, using an inactive EEG to define brain 
death is totally different than that using index values equal to zero, both theoretically 
and in practice. To obtain an inactive EEG, several measurement locations with a long 
interelectrode distance outside the frontal region must be used. Amplification and 
filtering have to be changed during the recording. The inactive EEG should be 
permanent, not only periodic, as in burst suppression. Residual EEG has been reported 
in clinically brain-dead patients. Grigg et al. (Grigg et al. 1987) reported that 20% of 
brain-dead patients had some residual EEG activity that lasted up to 168 h. This is in 
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line with the results of Study II, demonstrating preserved EEG activity in 25% of organ 
donors. The short delay between brain death diagnosis and the beginning of organ 
retrieval (420 min) may explain the relatively high incidence of preserved EEG activity.  
 
It has been stated, that no single test could confirm the disappearance of function of all 
cortical neurons (Guerit 2007). Clinical examination does not cover the whole brain, 
and even in optimal recordings, the persistence of a few hundred cortical neurons would 
be sufficient to produce identifiable EEG activity. Multimodality evoked potentials test 
only a part of the central nervous system. Even the techniques that demonstrate the 
arrest of cerebral blood flow may be inadequate to confirm whole-brain destruction. 
Persistent EEG activity has been found in some clinically brain-dead patients in whom 
four-vessel angiography demonstrated cerebral blood flow arrest (Grigg et al. 1987, 
Guerit 2007). The diagnosis of brain death has to be approached as a pathophysiological 
situation to make modern organ transplantation from brain dead-organ donors possible. 
It means verifying a pathophysiological process sufficient to cause irreversible and 
widespread neuronal destruction that prevents any persistence or eventual functional 
recovery of the neural networks required for human consciousness. However, even 
according to the pathophysiological approach, EEG may not be reliable in the context of 
brain death diagnosis, because it is sensitive to artifacts and metabolic disturbances 
(Guerit 2007). 
BIS and Entropy values decreased after administration of NMBAs, BIS significantly 
more than Entropy. EMG artifact may be more pronounced in cases with low-amplitude 
EEG signals. Despite the use of BIS-XP electrodes (the modern version of BIS 
electrodes that has been claimed to be more resistant to artifacts), EMG induced high 
BIS readings more often than high Entropy readings. However, administration of 
NMBAs was not controlled in the study protocol (Study II). Hence, the exact time of 
sustaining a 100% block was not recorded, and with longer operations, the block has 
faded over the course of time after the bolus dose of NMBAs. Therefore, we were 
unable to calculate whether the percentages of recorded time with an index value 
differing from zero remained significantly different between BIS, SE, and RE after 
NMBAs. As already discussed, the higher acceptable electrode impedance in BIS may 
increase the risk of artifacts compared with Entropy. 
 
An ECG artifact was reported to lead to apparently “normal” BIS values in a severely 
brain-injured patient with complete burst suppression in EEG (Myles and Cairo 2004). 
Among organ donors with absent or weak residual EEG signals, the role of the ECG as 
a potential source of artifacts should be emphasized. Falsely elevated Entropy and BIS 
values during complete suppression of the EEG signal were detected in Study II. Visual 
inspection of EEG recording revealed easily detectable QRS complexes of the ECG. 
Potential sources of error might be also in the algorithm of BIS and Entropy. Low- 
amplitude EEG has been described in elderly people during anesthesia. Whether such 
low-amplitude EEG could become erroneously interpreted as suppression by the index 
calculation algorithm has not been investigated. If dedicated studies were conducted, 
other potential sources of error might appear, disturbing index calculation at the low end 
of the scale. 
 
BIS and Entropy were developed to quantify hypnotic depth of GABA-ergic, drug- 
induced general anesthesia. For this purpose they perform well. When applying them 
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outside this originally described function, the potential sources of error should be 
known. Although Entropy may be more resistant to artifacts than BIS in brain-dead 
subjects, these indices are not diagnostic tools and should not be used to aid in the 
diagnosis of brain death. Diagnosis of brain death is based on clinical examination, and 
due to numerous artifacts, EEG-derived indices are not suitable for making this 
diagnosis.  
 
 
Performance of Surgical Stress Index (Surgical Pleth Index) in patients with 
clinically different analgesic levels (Aim 3) 
 
 
Surgical Stress Index (SSI, later Surgical Pleth Index, SPI) values recorded during the 
	rst two minutes after skin incision were signi	cantly lower in patients undergoing 
shoulder surgery with an interscalene plexus block than in patients without the block. 
Tetanic stimulation to the ulnar region of the hand resulted in an increase of SSI values 
only in the patients with plexus block not covering the site of electrical stimulation. 
Consistent with effective analgesia at the site of surgery, the need for opioids during 
surgery was signi	cantly lower in the plexus group. These findings support the 
usefulness of SSI for monitoring adequate analgesia during surgery. To date, no studies 
demonstrating the feasibility of SSI in ICU patients are available; thus, studies are 
needed before SSI or other analgesia monitories may be used in critically ill patients.  
 
SSI predicted a noxious stimulus (skin incision, tetanic stimulus) better than HR, blood 
pressure, or RE-SE difference, which have traditionally been considered signs of 
inadequate anesthesia. Pk for SSI to detect noxious stimuli was higher than for those 
traditional variables in all of the studied nociceptive incidents: after skin incision in the 
plexus vs. control groups, before vs. after tetanic stimulation in the control group, and 
before vs. after skin incision in the control group. BP was measured intermittently 
(Study III). Therefore, Pk value of BP is not strictly comparable with other variables 
after the tetanic stimulation because it was measured only every five minutes. This 
might be too long an interval to detect a noxious stimulus lasting only 30 s. The results 
of Study III are in line with the previous studies of Ahonen et al. (2007) and Stryus et 
al. (2007), in which SSI has also been found to correlate better with noxious stimuli 
than HR and BP. In all of these previous studies, SSI has been calculated offline, and 
compared retrospectively and separately with HR and BP. Study III was followed by an 
editorial (Hoymork 2008), in which further studies with SSI as a tool for titrating 
analgesics during surgery were demanded. 
 
When considering the results of Study III, it must be taken into account that exact Pk 
values are comparable only between identical study conditions. During this study, 
alfentanil was administered according to prede	ned clinical criteria without knowledge 
of SSI values. When SSI values were evaluated retrospectively, they were equal 
whether alfentanil was administered or not in the plexus group. In contrast to this, SSI 
values were higher if alfentanil was administered compared with the periods of no 
clinical signs of inadequate antinociception and no alfentanil administration in the 
control group. Thus, in the control group, traditional signs of inadequate antinociception 
and SSI values coincided. In the plexus group, the pain was adequately controlled, but 
changes in clinical parameters traditionally interpreted as indicating nociception 
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triggered alfentanil administration. SSI did not differ between the groups before skin 
incision. After the initial increase in SSI after the incision in the control group, frequent 
bolus doses of alfentanil decreased SSI values efficiently, and during the rest of the 
operation there were no signi	cant differences in SSI values between the groups.  
 
The population of Study III was heterogeneous with respect to the extent of the sensor 
and motor blockade. The block was tested before general anesthesia and considered 
efficiently analgesic for the shoulder surgery if it covered dermatomes C3-C6 and T2. In 
four patients, also the ulnar side of the hand was affected. Ulnar spread of the block did 
not affect nociception level during surgery (which was exclusively in the shoulder area), 
and thus, had an effect only on the results of tetanic stimulation. A delayed onset of 
ulnar block cannot be ruled out. However, most of the patients reacted to the tetanic 
stimulation, which would have been a surprising finding if they had had an effective 
ulnar block. Furthermore, even if second testing had been performed after recovery 
from general anesthesia, we still would not know whether the possible delayed block 
had started to take effect before or after the tetanic stimulation.  
 
Modern balanced general anesthesia aims at individually optimized dosing of 
anesthetics. The need for anesthetics varies between patients and also within the same 
patient following surgical events. Despite the overlapping effects of anesthetics, each of 
the components should be able to be modulated individually. With complementary 
information about patients’ hypnotic and analgesic balances available, the choice of 
medication might be more accurate in terms of expected effects and side-effects. SSI 
has been shown to be capable of differentiating decreases in HR achieved with opioid 
from those accomplished with a beta blocker (Ahonen et al. 2007). SSI provides 
continuous information about the nociception/ antinociception balance derived from 
circulation parameters that are routinely monitored in all patients under general 
anesthesia. An optimal range for SSI during anesthesia has not yet been recommended. 
A definition of acceptable activation of the sympathetic-adrenergic system with noxious 
stimulation during surgery is lacking. Systolic blood pressure values were significantly 
higher during surgery in the control group than in the plexus group. In addition, BPsys 
remained constant in the plexus group during surgery, but tended to increase in the 
control group. Based on this study alone, the highest acceptable level of sympathetic-
adrenergic activation for the general well being of the patients cannot be determined. 
However, the study did show that SSI reacted consistently to sudden expected changes 
in sympathetic activation and its inhibition. 
 
SSI was calculated from PPGA recordings of the contralateral hand to the surgery in 
both groups. A blockade of the sympathetic nervous system may change circulation also 
on the contralateral side (Landsverk et al. 2006), which might have had an influence on 
PPGA readings in the plexus group. Hypothermia, hypovolemia, arrhythmias, and 
medication affecting the autonomic nervous system may also impact SSI values, but 
they were not analyzed in this study. Monitoring of central venous pressure and body 
temperature may clarify other potential factors that have an independent effect on SSI. 
Further studies are needed to evaluate the effect of these possibly confounding factors 
on SSI.  
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Ability and time schedule of the quantitative EEG-derived indices in 
differentiating patients with good and poor neurological recovery after cardiac 
arrest (Aim 4)  
 
 
The quantitative EEG variables BSR, RE, SE, and WSE were associated with 
neurological outcome after cardiac arrest in mild hypothermia-treated patients during 
the first 24 h (BSR, RE, and SE), and between 24 and 48 h (BSR and WSE). Status 
epilepticus after cardiac arrest was associated with significantly lower WSE and with 
death. WSE detected three of four patients with status epilepticus. 
 
Prediction of neurological recovery after successful resuscitation from cardiac arrest is 
generally thought to require several days (Edgren et al. 1994, Zandbergen et al. 1998). 
In the present study, associations of RE and SE with discrimination between good and 
poor outcomes during the first 24 h were demonstrated. However, it should be noted 
that while Entropy algorithm detects burst suppression in the EEG, SE and RE are also 
calculated using burst-suppression information, and therefore, they have a strong 
correlation with BSR. BSR maintained its association with poor outcome during 24–48 
h after cardiac arrest, but SE and RE did not. The result suggests that continuity of the 
EEG signal is the relevant feature associated with outcomes. This is in line with a recent 
study demonstrating that BIS and suppression ratio predicted outcome even better than 
ROSC (Seder et al. 2009). Deep hypothermia may result in high BSR without an 
association with poor outcome, but EEG is not significantly affected at a body 
temperature of 33°C, which is commonly used in hypothermia treatment (Michenfelder 
and Milde 1991, Stecker et al. 2001). In the present study, the depressive effects of 
hypnotics and analgesics on EEG readings during hypothermia are obvious, but are 
equal in both outcome groups. The use of midazolam and fentanyl has not been related 
to increased suppression in healthy volunteers. Barbiturates, propofol, etomidate, and γ-
hydroxybuturate increased BSR in a dose-dependent manner. The critical range of 20-
25% of BSR measured 24-96 h after admission to the ICU correlated with poor 
outcome. (Theilen et al. 2000). Similarly, in the present study, a decision boundary at 
20% mean BSR at 24 h after cardiac arrest would have resulted in 89% sensitivity and 
57% specificity for detection of poor outcome.  
 
In previous studies, status epilepticus in original EEG monitoring has been associated 
with poor outcome (Young and Doig 2005, Rundgren et al. 2006). All of our patients 
with status epilepticus died. Because these patients were paralyzed, their status was 
nonconvulsive, thus visible only in the EEG, and was detected when data were analyzed 
offline for study purposes. Hence, no specific treatment to abolish status could be 
undertaken. Only sub-hairline EEG channels were used, and therefore, possible 
localized epileptiform activity elsewhere was not detected. Duration of seizures and 
delay to diagnosis are associated with increased mortality (Young et al. 1996). Based on 
these and previous results, continuous EEG monitoring in all comatose patients should 
be adopted.  
 
WSE has previously been used to quantify epileptiform activity during sevoflurane 
anesthesia (Särkelä et al. 2007). In the present study, a gradual decrease in median WSE 
values was demonstrated from 12 h before onset of status epilepticus in three of four 
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status epilepticus patients. Decreasing WSE value might alert ICU care providers 
unfamiliar with EEG of threatening status epilepticus. However, the WSE method has 
thus far been studied only during sevoflurane anesthesia and now among cardiac arrest 
patients. It has been shown to react to epileptiform activity, but not to typical EEG 
patterns of anesthesia, except for burst suppression. Before WSE could be considered a 
clinically reliable tool in intensive care, further studies with larger patient material are 
required. Low WSE values caused by eye movements and burst suppression without 
epileptiform activity should be identified (Särkelä et al. 2007). WSE should also be 
studied in connection with different kinds of encephalopathy caused by critical illness. 
For a definite diagnosis of status epilepticus, the traditional multichannel EEG is still 
irreplaceable. 
 
The limited number of patients did not allow statistically reliable testing of the 
prediction properties of the measured indicators. However, preliminary results of the 
prediction powers of selected indicators are presented. An outcome prediction analysis 
with a stepwise Bayesian approach was performed to examine the prediction power of a 
combination of EEG parameters and biochemical markers. Compared with other tested 
parameters (NSE 24 h and BSR 24 h), WSE (from the first 24 h) and S-100B (when 
rewarmed to 35.5°C) predicted outcome most accurately. The model predicted correctly 
the outcomes of 26 of the 30 patients, resulting in a sensitivity of 89%, specificity of 
86%, PPV of 73%, and NPV of 95%. To validate these promising preliminary results, 
the classification model should be tested with a separate independent group of patients. 
 
S-100B was lower in patients with good outcome than in patients with poor outcome 
already on arrival to ICU. After mild hypothermia treatment, both S-100B and NSE 
values were lower in the good outcome group. Both S-100B and NSE values had a 
decreasing trend in the good outcome group and an increasing trend in the poor 
outcome group. This study is in line with that of Tiainen et al. (2003) when considering 
NSE values, but not S-100B values, as prognostic markers in hypothermia-treated 
cardiac arrest patients. Although having similarities in study populations, treatment 
protocol, and design, these studies also have major differences. Tiainen et al. focused on 
the time course of serum NSE and S-100B in hypothermia- compared with 
normothermia-treated ICU patients. They did not find an association between the trends 
of S-100B measured 24 and 48 h after cardiac arrest and outcome, nor did they find a 
difference in the levels of serum S-100B between good and poor outcome in 
hypothermia-treated patients at 24 h.  Tiainen et al. considered the clinical prognostic 
value of S-100B to be poor because of the remarkably low sensitivity (20-30%) when 
specificity was at least 95%. In the present study, the sensitivity of S-100B was slightly 
better, 38% with specificity of 100%, when S-100B was measured either on arrival to 
ICU or when patients had been rewarmed to 35.5°C (31-32 h after cardiac arrest). S-
100B was measured earlier than in the study of Tiainen et al., namely on arrival to ICU 
and 31-32 h after cardiac arrest. The different time-points make it more difficult to 
compare the results from these two studies. The discrepancy may be also related to the 
relatively small number of patients in both studies. The biologic half-life of S-100B is 
very different from that of serum NSE, only 0.5-2 h, and thus, earlier measurements of 
S-100B may better reflect the initial degree of hypoxic-ischemic damage. Hachimi-
Idrissi et al. (Hachimi-Idrissi et al. 2002) have previously reported that S-100B 
measured upon arrival at hospital differed significantly between patients who recovered 
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consciousness and those who did not, but their patients were not treated with 
hypothermia.  
 
The pulsatile index of TCD was significantly lower in patients with good outcome than 
in patients with poor outcome. The result of the present study is comparable with that of 
Soehle et al. (Soehle et al. 2007), indicating that a pulsatile index higher than 0.8 was 
predictive of unfavorable outcome after subarachnoid hemorrhage. A pulsatile index 
higher than 2.0 has been associated with increased intracranial pressure among 
comatose patients with liver failure (Aggarwal et al. 1993). 
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7. Conclusions 
 
 
The following conclusions can be drawn from these studies: 
 
 
1. The incidence of intraoperative awareness and explicit recall during general 
anesthesia was not increased in outpatients relative to inpatients, in fact being 
even lower in outpatients than inpatients. 
 
2. In brain-dead organ donors, values of Spectral Entropy, Response Entropy, and 
BIS differed significantly from zero during organ retrieval. The value of RE was 
greater than that of SE, and the value of BIS was greater than that of SE or RE. 
Sources of artifacts were as follows: electrode artifacts (electrocauterization and 
handling of patient, in 81% of recordings), ballistocardiography (44%), 
electromyography (38%), 50-Hz artifact (25%), and electrocardiography (19%). 
The highest index values were recorded without muscle relaxation. Entropy was 
more resistant to artifacts than BIS. 
 
3.    Surgical Stress Index (SSI, later Surgical Pleth Index, SPI) was significantly 
lower in patients with effective antinociception (brachial plexus block) in 
response to tetanic stimulation and skin incision. Pk for detecting nociceptive 
reactions was higher for SSI than for HR, noninvasive blood pressure, or RE-SE 
difference. SSI may offer a useful tool for determining adequate analgesia 
during surgery. 
 
4.   The EEG-derived indices (burst suppression ratio, Response Entropy, State 
Entropy, and wavelet subband Entropy) differed in hypothermia-treated patients 
with good and poor neurological outcome after cardiac arrest during the first 24 
h (BSR, RE, and SE) and between 24–48 h (BSR and WSE). Prolonged high 
BSR, discontinued EEG, and status epilepticus indicated poor prognosis. Lower 
WSE was associated with status epilepticus and death. 
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8. Clinical considerations 
 
 
1. Outpatients undergoing general anesthesia are not at increased risk for 
intraoperative awareness and explicit recall relative to inpatients.  
 
2. In clinically brain-dead patients, BIS and Entropy values may differ considerably 
from zero due to artifacts. Persistent, unphysiologically distributed, nonreactive 
EEG activity is found in a considerable proportion of clinically diagnosed brain- 
dead patients. Several artifacts disturb the adequacy of BIS and Entropy 
monitoring during an organ harvest operation. Entropy seemed to be more 
resistant to these artifacts than BIS. However, these indices should not be 
considered an indicator of brain death.  
 
3. Surgical Stress Index detected nociception better than HR, blood pressure, and 
RE-SE difference. Before commercially available depth-of-analgesia monitors 
became available for clinical use, further studies are needed to evaluate the 
clinical feasibility of SSI to titrate analgesia during general anesthesia.  
 
4. In addition to conventional EEG and long-term monitoring, the EEG-derived 
indices may be used for early prognostication of neurological recovery after 
cardiac arrest. The number and length of suppressed EEG periods (BSR) seem to 
be the most relevant features associated with neurological outcome. Continuous 
EEG monitoring of all comatose patients should be recommended to detect 
nonconvulsive, fatal status epilepticus. Decreasing WSE value might alert 
medical personnel to the existence of status epilepticus, but normal WSE is not 
reliable in excluding status epilepticus. 
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